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ABSTRACT
For the potential benefit of progenitor cells to be realized in cell-based clinical therapies, it is
vital to investigate the mechanism between progenitor cells and abnormal tissue formation.
Laminitis is a fatal condition that is often presented by equine hoof inflammation and hoof
tissue disarrangement. The persistence of abnormal tissue formation after the resolution of
equine laminitis suggests there is progenitor cell compromise. So far, there is limited
information about equine hoof progenitor cells and the effects of inflammation on hoof
progenitor cells. To pursue a better understanding of both hoof progenitor cell and hoof
growth as well as find potential progenitor cell-based treatments for hoof injuries, we choose
hoof progenitor cells to create an in vitro model to study hoof cell characteristics. Primary
progenitor cells were isolated from fresh equine laminae as well as cryopreserved laminar
tissue and characterized in vitro. Results indicate hoof progenitor cells from fresh tissue have
multilineage differentiation capacity and show similar cell doublings, CFU frequencies,
surface antigen, and gene expressions when compared to other reported stem cells. The
majority of hoof progenitor cell isolates are K14+CD105+ population that may result from
the specific dermal-epidermal hoof structure. K14+CD105+ progenitor cells, progenitor cells
from unaffected, laminitic and cryopreserved laminar tissue show different cell behaviors on
decellularized laminar scaffolds and distinct ultrastructural morphology. This indicating hoof
progenitor cells have variable metabolic and synthetic capabilities determined by different
preharvest tissue conditions and postharvest conditions. K14+CD105+ progenitor cells have
a stronger proliferation rate and higher epithelial to mesenchymal transition (EMT) marker
expression compared to heterogeneous cell isolates. This suggests that cell plasticity required
to maintain both the interface and two tissue types may be enhanced by EMT capabilities.
Cells loss epithelial characteristics by culturing with inflammatory cytokines while normal
matrix may promote epidermal gene expression. EMT protein expression was increased by

ix

culturing with medium containing inflammatory cytokines, which indicating inflammatory
cytokines may support a propensity for EMT. Overall, outcomes in this dissertation provide
invaluable information for a better understanding of hoof cell composition and hoof disease
prevention. Likewise, the work informs future progenitor cell-based dermal-epidermal tissue
engineering.

x

CHAPTER 1. THE EQUINE HOOF: INFLAMMATION AND
PROGENITOR CELLS
1.1. Equine hoof laminitis and progenitor cells: history and current situation
Aristotle described the relationship between laminitis, inflammation of the equine hoof, and
overfeeding of barley around 350 BC. [1] The condition is commonly called “founder”.
Currently, the incidence of laminitis is approximately 34%, with an estimated lifetime risk of
15% in north America. [2, 3] There are descriptions of laminitis, defined as inflammation of
sensitive hoof tissues but recognized as pathologic changes with or without inflammatory
mediators, or from endocrine and metabolic diseases, in the earliest records of domesticated
horses. Despite decades of research focused on this devastating disorder, there has been
relatively little progress to prevent or treat it. Decades of research contribute to contemporary
standards of care that include systemic and local therapies as well as mechanical hoof support.
[4, 5] Descriptions of hoof wall inflammation, laminitis, exist in some of the earliest records
of domesticated horses. Laminitis severity can range from mild to serious, and signs can be
acute, chronic, or transition from acute, severe inflammation to permanently weakened,
disordered tissue. Regardless of the duration of laminitis, tissue damage tends to occur within
the intricate dermal and epidermal hoof connections on the primary and secondary lamellae.
Disruption of tissue integrity is associated with lifelong changes to hoof growth, repair, and
conformation. Current clinical and laboratory research contribute to the understanding of cell
signaling pathways that include epithelial to mesenchymal transition pathways. Despite this,
consistent mechanisms to restore healthy tissue formation following an inflammatory insult
are lacking. The ability of endogenous and exogenous progenitor cells to contribute to and
direct healthy tissue formation is established for most tissues. Relatively little information is
currently available, however, about equine hoof progenitor cells. Equine hoof anatomy, tissue
inflammation, and progenitor cells are covered in this review. The potential of progenitor
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cells to advance in vitro equine hoof tissue models and translate to clinical therapies may
significantly advance prevention and treatment of a devastating condition that has afflicted
equine companions throughout history.
1.2. Equine hoof structure, growth and keratins
The equine hoof capsule, composed of modified epidermis and dermis, is vital for protecting
the third phalanx while propagating forces of locomotion from the ground to the limb. Hoof
wall has three layers including stratum externum (tectorium), medium, and internum
(lamellatum). The stratum externum is composed of cornified tissue formed by germinal cells
in the perioplic corium located superficial to the coronary corium that produces the stratum
medium. [6] The thickest stratum medium layer is consist of both pigmented intertubular and
tubular horn. [7] As new cells are formed in the coronary band; the existing cells are pushed
distally and eventually cornify. [8]
Stratum internum is composed of epidermal and dermal lamellae, that are continuous with the
tubular horns of the stratum medium and the periosteum of the distal phalanx, respectively
(Fig. 1). The suspensory apparatus of the distal phalanx is a network of collagen bundles that
connects the distal phalanx to the stratum internum and permits the hoof wall to act as a
principal weightbearing structure. [9] Collagen bundles extend from the distal phalanx and
insert on the laminar basement membrane between the secondary dermal and epidermal
laminae. [10] The lamellae epidermis is non-sensitive and avascular, but dermis has blood
vessels and in a dense matrix of tough connective tissue. [11] Both primary epidermal and
dermal laminae are frond-like shapes that have smaller frond-like structures, secondary
laminae, on their surface. The junction between the epidermal and dermal components of the
lamellae is a complex basement membrane to which epithelial basal cells are attached via
hemidesmosomes or electron dense adhesion plaques and the dermis is connected via
insertion and anchoring fibrils composed of proteins like collagen and laminin. [12, 13] The
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highly complex morphology of the primary and secondary laminae can vary regionally, likely
due to different functions. [14]

Figure 1. Illustration of the internal components of the equine hoof in images with no (b) to
progressively higher (c, 10x; d, 20x) magnification. The perioplic corium (b, PC) and
coronary corium (b, CC) are shown in addition to the primary epidermal (c, PEL, black arrow)
and dermal (c, PDL) lamellae and the secondary epidermal (d, SEL) and dermal (d, SDL)
lamellae. P3 = Third phalanx.
Keratins are the major structural proteins, largest subgroup of intermediate filament proteins,
and vital cell signaling participants in epithelial cells. They are non-soluble proteins with
distinct physicochemical properties, intermediate structures, and mechanical behaviors that
broadly divide them into soft or hard keratins and contribute to the variable properties of
different hoof regions. [15-17] Disulfide bonds within keratin filaments convey strength and
hardness proportionate to the number of bonds present, and hard keratins tend to have more
than soft. [18] Amino acid sequences determine the secondary, tertiary and quaternary
structures of keratins. [19] They are often combined with other proteins like keratin filamentassociated proteins and mineral binding enzymes and can vary from fibrous to amorphous.
[20, 21] In the epidermis, keratins produced by keratinocytes exist as keratohyaline granules

3

within the cells. [22] Keratin 14 is a cytokeratin typically found in the cytoskeleton of
epidermal cells that is expressed by basal cells between the secondary epidermal and dermal
lamellae (Fig. 2). As the names imply, soft keratins are typically the largest component of
relatively soft cornified epithelia, while hard keratins are the major population in hard
cornified tissue like the hoof wall.
The type and number of keratins within a tissue tend to change with age and pathology. [23,
24] Accordingly, there are distinct differences in keratins within the stratum lamellatum of
unaffected versus inflamed hooves. In endocrinopathic laminitis, laminar tissue is partially
replaced with aberrant keratin, and keratinization of primary epidermal lamellae is markedly
increased compared to normal. In addition, keratinocyte hyperproliferation is documented in
hooves affected by insulin-induced laminitis. [25, 26] Abundant keratohyalin in the normal
hoof stratum externum and cytokeratins in epidermal basal cells are not evident in inflamed
hoof tissue. [27] Cytokeratin 14 clusters around the nucleus in hooves with carbohydrate
overload induced laminitis compared to the normal cytoplasmic location. [28] Based on this
information, changes in keratin content and location provide a unique mechanism to
determine cell phenotype, maturity level, and pathology within equine hoof tissue.

Figure 2. Fluorescent photomicrographs showing fluorescent labeling of keratin 14 (arrow,
green), in basal cells between secondary epidermal (SEL) and dermal (SDL) lamellae within
the stratum internum of equine hoof tissue. Nuclei are stained blue.
The hoof wall of a normal adult horse grows at a rate of approximately 0.24-0.4 inches (6-10
millimeters) per month. [29] Stratum medium growth occurs by division of epidermal basal
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cells on papillae within the coronary corium. [9] As the basal cells (Fig. 3) divide, they drive
older cells toward the ground surface to create the tubular and intertubular horns of the hoof
wall. [6] There are several reports surrounding tissue growth in the stratum internum that is
thought to occur, in part, by proliferation of basal cells on the proximal lamellae. Theories
exist about the process by which the strong attachment with the stratum medium is
maintained while it grows downward. [8] It is generally agreed that tissue homeostasis
includes balanced synthesis and enzymatic degradation of extracellular matrix by resident
cells. Proteins like tissue inhibitors of metalloproteinases (MMPs) are crucial to the process.
[30] Disruption of tissue homeostasis by upregulation of neutrophil MMP (e.g., MMP2 and
MMP9) production of proinflammatory cytokines such as interleukin (IL) 1β and 8 are
thought to contribute to destruction of the epidermal-dermal interface in inflamed tissue. [31,
32] Within the basement membrane, laminin stabilization of the epidermal-dermal tissue
attachment is targeted by MMPs during laminitis. [33] While it is clear that coordination of
tissue production and degradation is disrupted by inflammatory mediators, the exact
contributions of and consequences to resident progenitor cells have yet to be determined. [34]

Figure 3. Transmission electrophotomicrograph of a desmosome like structure (arrow)
between passage 3 cultured cells from equine hoof stratum lamellatum.
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1.3. Inflammatory mediators and inducible laminitis models
There are four recognized stages of laminitis, developmental, acute, subacute and chronic.
[35] The developmental phase occurs between the first insult and the appearance of initial
clinical signs. The acute phase is from first clinical signs to displacement of the third phalanx,
thought to result from a combination of tension from the deep digital flexor tendon, weight
bearing forces, and breakdown of the dermal-epidermal junction. Subacute condition is
classified as no displacement of third phalanx within 72 hours. Subsequent laminar tissue
failure with progressive third phalanx displacement is regarded as chronic laminitis (Fig. 4).
[35, 36]
Laminar tissue inflammation can occur secondary to any number of systemic or local insults.
Inflammatory mediators, circulatory compromise, and compression injury may all contribute
to tissue damage. [37, 38] Predisposing conditions for laminitis are numerous, range from
equine metabolic syndrome to pituitary pars intermedia dysfunction, and most are associated
with some level of systemic inflammation mediated by cytokines and hormone imbalance.
[39] Obesity is thought to increase predisposition to laminitis by disrupting hoof homeostasis,
in part, by adipose tissue production of inflammatory cytokines like tumor necrosis factor
(TNF)-α, IL-6, and IL-1β, all of which decrease insulin receptor signaling and insulin
sensitivity. [40] Obesity is also associated with elevated cortisol levels from overexpression
of 11β-hydroxysteroid dehydrogenase-1 in human patients and horses with insulin resistance,
type 2 diabetes, and hyperlipidemia. [41] Besides the inciting cause, hoof inflammation can
seriously damage the crucial epidermal-dermal bond that maintains structural integrity of the
hoof soft tissues. Potentially due to differences in the root cause of the inflammation as well
as individual characteristics, disease severity and progression vary widely.
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Figure 4. Radiographs of an unaffected (A) and laminitic hoof (B). The third phalanx (P3) is
rotated and displaced distally in the radiograph of the hoof with laminitis.

To study the chronology and pathophysiology of hoof inflammation, toxicants and high doses
of naturally occurring proteins have been used historically to repeatably induce the condition
in horses for sequential evaluations from the onset. Pathologic changes vary with toxin and
dose. [42-44] Use of endotoxin to cause laminitis was abandoned since it created systemic
and local signs of laminitis, but it did not cause tissue changes characteristic of the condition.
[45, 46] Carbohydrate overload (CHO) with corn starch and wood cellulose flour or black
walnut extract (BWE) cause microstructural changes in the hoof that resemble those of
naturally occurring laminitis. [42, 47] Oligofructose derived from chicory root and
hyperinsulinemia are also used to create inflammatory conditions in the hoof. [43, 48] Years
of research have resulted in a diverse set of mechanisms to induce hoof inflammation for
purposes of study.
As previously indicated, the lamellae appear to be the most vulnerable to the consequences of
laminitis. Given the role of resident cells to tissue homeostasis and repair, careful
consideration of changes in both cells and tissue is necessary to compare the models of acute
laminitis to the naturally occurring condition (Table 1). In models and naturally occurring
laminitis (Fig. 5), innate and adaptive immune cells accumulate around microvasculature and
the stratum lamellatum epidermal-dermal interface (Table 1). [49, 50] Calprotectin, an
inflammatory protein, is expressed by extravasated white blood cells on the epidermal side of
7

the basement membrane in natural and induced laminitis. [51, 52] Microstructural damage
and cell loss on and around the basement membrane is comparable among models and
laminitis; however, changes in naturally occurring laminitis can be subtler than
experimentally induced laminitis. Basal cell cytoskeleton collapse is associated with glucose
deprivation

and

metalloproteinase

activation

in

the

oligofructose

model.

[32]

Hemidesmosomes between basal cells are lost in the oligofructose, CHO, and insulin models.
[53-55] In the CHO model, there is basement membrane necrosis and loss of epithelial cells
between the secondary epidermal and dermal lamellae. [56] With high-dose insulin, laminar
epithelial cells are abnormally elongated and subject to dyskeratosis and apoptosis. [25, 57]
Gene and protein expression between natural and induced laminitis are somewhat comparable.
In natural laminitis, p63, a regulator of epidermal stem cells decreases, while proteins
involved with vascular inflammatory reactions like gamma-histoneH2A and endothelin-1
expression increase. [26, 58, 59] Inflammatory interleukins like IL-8, IL and IL6 are typically
increased and anti-inflammatory interleukins alike IL-10 decreased in the BWE and
oligofructose models. [60] Cell signaling is disrupted in the oligofructose and CHO models.
Of particular note is that suppression of the Wnt signaling mechanism necessary for
mesenchymal to epithelial transition of basal epithelial cells in the CHO model potentially
interferes with commitment to the epithelial lineage necessary for organized epithelial tissue
formation. [61] Basal cell gene expression of factors associated with both cell connections
and communication like β-catenin and integrins in the CHO model and insulin growth factor
receptor expression in the insulin model are reduced. [62, 63] Induction of laminitis in
otherwise normal hooves is one mechanism to study the acute pathogenic mechanisms of the
condition for potential therapeutic targeting. Unfortunately, the models do not exactly
replicate the natural course of the disease that often includes persistent abnormalities in hoof
tissue production and maturation. Focus on viable, immature cells that contribute to tissue

8

formation and repair is likely to reveal a new avenue of discovery in the quest to counteract
the life-changing effects of laminitis.
Table 1: Comparison of Microstructural Tissue Changes from Induced and Natural Laminitis.
BWE: black walnut; CHO: carbohydrate overload; OF, oligofructose.
Model

BWE

CHO

OF

Insulin

Natural Occurring
Laminitis (chronic)

Leukocyte
Accumulation
Disrupted Cell
Signaling

Yes[50]

Yes[49]

Yes[64]

Yes[56]

Yes[65]

Increased
CD163 and
signal
transducing
activator of
transcription 3
(STAT3)
expression[62,
66]

Wnt pathway
suppression;
Reduced β-catenin
and integrin β4
expression[61, 67]

Increased IL6,
Cyclooxygena
se 2 (COX2),
Chemokine
(C-X-C motif)
ligand
(CXCL),
membrane
cofactor
protein (MCP)
expression[60,
68]

Decreased
insulin like
growth factor
receptor 1 (IGF1R)
expression[69]

Decreased P63
expression
Increased
gamma-H2AX
and endothelin-1
expression[26,
59, 60]

Yes[52]

Yes[54, 56]

Yes[53, 70]

Yes[25, 55]

Yes[32]

Yes[52]

Yes[49]

Yes[51]

Yes[51]

Yes[65]

Epithelial
Basal Cell
Damage and
Loss
Calprotectin
Positive Cells

Figure 5. Fluorescent photomicrographs of the stratum internum from an unaffected (a) and
laminitic (b) hoof with nucleii stained blue (DAPI). The lamellae are misshapen in the
laminitic hoof.
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1.4. Multipotent progenitor cells and ectodermal progenitor cells
Adult MSCs are routinely isolated from numerous tissues in the horse. [71, 72] Tissue stroma
is derived from mesoderm, and undifferentiated cells in the space retain the capacity to alter
their morphology and function to address the tissue repair and maintenance needs. [73] By
definition, adult MSCs exhibit specific characteristics in vivo like the ability to adhere to
polystyrene and the capacity to differentiate into distinct cell types from the same embryonic
layer under specific induction conditions (Fig. 6). [74, 75] Additional criteria set by the
International Society of Cell Therapy are the expression of some or all of a panel of surface
antigens including CD105, CD44, CD29, CD73, CD90 and no expression of CD45, CD34,
CD14, CD11b, CD19 as well as lineage-specific protein and gene expression following
chemically-induced differentiation. [76, 77] Other stem cell markers often applied to identify
MSCs include markers associated with embryonic development like octamer-binding
transcription factor 4 (Oct-4), stage-specific embryonic antigen-3 (SSEA-3), stage-specific
embryonic antigen-4 (SSEA-4) and podocalyxin (TRA-1-60). [78, 79] However, MSCs
typically possess some capacity for self-renewal, though not immortality like totipotent cells,
and they have variable immune-privilege. [80]
Primary cell isolates are usually heterogenous collections of cells with multiple
immunophenotypes that reflect different plasticity and maturity. [81] Despite this, the cells
have characteristic microstructure and ultrastructure. [82] Current knowledge supports that
progenitor cells can differentiate into distinct cells from similar origins as well from other
embryonic layers, a process commonly referred to as transdifferentiation. [83] They also
maintain the capacity to “regress” to an earlier stage of development both by natural and
synthetic means. [84] Additionally, exogenous MSCs can both guide and be guided by
endogenous cells. Despite similar behaviors and morphologies, undifferentiated cells vary
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among species and tissues. [85] This requires individual characterization to elucidate the
distinct properties and potential of cells from each parent tissue and species. [76, 77]
The ability to culture and manipulate progenitor cells in vitro creates a plethora of
opportunities to study normal and abnormal tissue regeneration to direct progressive
therapeutic discovery and translation of cellular therapies. [86] Autologous and autogenous
MSCs appear to promote tissue healing, including hoof, in horses and other species. [87]
Despite this, epigenetic factors are thought to influence the plasticity of progenitor cells, with
cells from a given tissue having the best potential to help repair that tissue. [88] Reports are
mixed surrounding of the efficacy of non-tissue specific MSC therapies in the hoof and other
tissues like the tendon, potentially due to the consequences of epigenetic programming that is
not overcome by limited in vitro manipulation. [89-91] This evidence strongly supports the
need to isolate and characterize progenitor cells from the hoof to understand the effects of
inflammation on them as the potential of exogenous cells or neotissues to reverse or prevent
the disease process.
Flow cytometry and fluorescence activated cell sorting (FACS) are universal tools to quantify
distinct cell characteristics within a heterogeneous progenitor cell isolate. Flow cytometry is
used to differentiate cells based on size, volume and intensity of fluorescence from labeled
antibodies that bind to antigens of interest on or within the cells. [92] The system is typically
composed of a “flow” mechanism by which cells pass through a detection apparatus
composed of a laser activator and light detectors. The light scatter is used to evaluate size and
fluorescence detectors quantify light intensity within specific wavelength ranges. [93] FACS
is a more complex form of flow cytometry that relies on most of the same concepts but has
the added feature of sorting the cells based on size and fluorescence. To accomplish this an
electrostatic charge is applied to fluid droplets containing individual cells. Based on the
presence or absence of a charge, the cells are collected into distinct reservoirs. [94, 95] The
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process of cell sorting is performed with live cells to allow culture following separation. The
level of complexity varies among flow cytometry and FACS systems and can include
relatively few to many detection channels to permit separation of cells expressing a wide
assortment of proteins.

Figure 6. Photomicrographs of laminar progenitor cells following culture in adipogenic (a),
osteogenic (b) or neurogenic (c) induction medium as well as stromal medium (d, e, f).
Adipose droplets(red), calcium deposits (red) and microtubule-associated protein 2 (Map2)
protein expression (green) were stained with oil red O (a, d), alizarin red (b, e) and anti-map2
with anti-mouse IgG (c, f), respectively. Nuclei were stained with DAPI (c, f, blue).
Epidermal progenitor cells, are, as the name implies, derived from the embryonic ectoderm.
[96] They inhabit the basal layer of the epidermis and participate in tissue repair and cyclic
renewal under the direction of growth factors like epidermal and fibroblast growth factors.
[97, 98] Like MSCs, they also possess the capability to differentiate in distinct cell lineages
from multiple embryonic layers. [99] Notably, MSCs are reportedly capable of assuming an
epidermal phenotype. Keratin composition changes with maturation stage well as specific
function(s) (Fig. 7). [19] As cells mature from basal cells to transient amplifying cells,
epidermal keratinocytes, and cornified epithelium, keratin expression changes. One example
is the maturation of human epithelial progenitor cells that change keratin expression from
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keratins 7,8,17,18, and 50 to keratins 6 and 16, followed by keratins 1 and 10, and finally
keratins 2 and 9. [24, 100] Keratins 5, 15, and 19 are typically expressed by immature cells.
[101] Human epidermal stem cells and transit-amplifying cells have been distinguished by
high integrin-1β and low rhodamine binding versus low to medium integrin-1β expression
and high rhodamine, respectively. As the progenitor cell knowledge base expands, so does
awareness of distinctions between unique cell populations. [102] Continued diligence to
maintain nomenclature and standards will support consistency and repeatability in progenitor
cell research.
Skin progenitor cells from most species have comparable plasticity to progenitor cells from
other tissues and can mature into multiple lineages including bone, adipose tissue, nerve, and
liver. [97, 103] Several immunophenotypes have been identified among species like K15+,
CD34+ immature keratinocytes from canine hair-follicle tissue and CD29+, K19+ cells from
human, murine and porcine skin.[98, 99] The markers CD34 and K6 are also used to identify
and isolate keratinocytes. [104] Coexpression of keratins 15 and 19 by basal keratinocytes
decreases with age and indicates cell self-renewal and tissue production capabilities in human
skin. [101, 102] Fibroblast-like stem cells from human foreskin express CD90, CD105,
CD166, and CD73 which are also found on human bone marrow derived MSCs. [105, 106]
This information confirms a wide variety of epidermal progenitor cells within heterogeneous,
primary cell isolates, establishes plasticity of the cells, and highlights common surface
antigens with MSCs.
Failure of basal cell proliferation or keratinocyte maturation are associated with mild to
serious and potentially life-threatening skin pathology. [107] A study about human scalp hair
follicle progenitor cells in bald versus hairy scalp showed that there was no difference in the
number of K15+ progenitor cells, but that the number of CD200+, CD34+ cells was lower in
bald scalp, leading to the conclusion that a failure or difference in maturation was the primary
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distinction between the two conditions. [108] On the other end of the spectrum is
epidermolysis bullosa, an inherited skin disorder in humans and horses associated in which
depleted progenitor cells and disrupted homeostasis in the skin that as blistering or sloughing
epidermis. [109] The underlying pathology of the disease is failure of anchoring proteins like
laminin and collagen at the dermal-epidermal junction due to variable genetic mutations. [13,
110] Injection of mesodermal or epidermal progenitor cells injected into lesions has
reportedly promoted local healing of lesions. [111] This leads credibility to the potential for
exogenous progenitor cells or cell factors to restore healing potential to damaged or
compromised tissue.

Figure 7. Fluorescent photomicrographs of cultured equine hoof progenitor cells stained with
anti-K14 and anti-mouse IgG-488 (green). Nuclei are stained with Hoechst dye (blue).
1.5. Hoof progenitor cells
The epidermal-dermal interface in the stratum lamellatum is unique to the hoof in horses and
the periodontal membrane and fingernail bed in humans. [112, 113] Isolation and culture of
hoof progenitor cells has only recently been described in contrast to isolation of progenitor
cells from the other interface tissues (Fig. 8). Current knowledge supports that primary
progenitor cell isolates from normal and inflamed equine hoof stratum lamellatum express
ectodermal (K14, K15, K19) and mesodermal (CD29, CD44, CD105) genes and proteins, and
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they have both ectodermal (neurogenic) and mesodermal (osteogenic, adipogenic)
differentiation abilities. [114] Further, equine hoof progenitor cells share some ultrastructural
features of both epidermal and mesodermal equine progenitor cells like intracellular vacuoles
and well-developed dilated rough endoplasmic reticulum cisternae (mesodermal) and cell
surface microvilli (ectodermal). [115, 116] Hoof progenitor cells also produce extracellular
matrix on scaffold carriers composed of either polyester or mineral material and on
decellularized lamellar matrix scaffold carriers in vivo, confirming the ability to form
neotissue on custom templates. This suggests that in vitro cell models of the equine stratum
internum may be an alternative This information suggests that in vivo induction of the
condition in otherwise normal hooves.
The description of equine hoof progenitor cell isolation is typical of collagenase tissue
digestion for progenitor cell isolation from adipose tissue and skin with various collagenases
(e.g., type I or type III), followed by separation of the cells from tissue remnants with
combinations of filtration, gravity separation, and centrifugation. [117, 118] Notably,
progenitor cells from cryopreserved, intact equine hoof stratum lamellatum have also been
isolated by collagenase digestion. [119] Unlike cells isolated from cryopreserved periodontal
ligament that were indistinguishable from fresh cell isolates, the cells from cryopreserved
hoof tissue show signs of senescence including an irregular cell membrane, electron-dense
cytoplasm, poorly organized rough endoplasmic reticulum, and aggregated chromatin (Fig. 9).
[120] Cryopreservation is reported to “age” fresh cell isolates, and in vivo behavior, plasticity,
growth rate and expansion potential are impacted accordingly. [121, 122] As such, most
reports caution against consideration of continuously cultured and revitalized cells as the
same. [120, 123] It is to distinguish between cryopreserved versus continuously cultured hoof
progenitor cells as well as those isolated from fresh versus cryopreserved tissue given
potential differences between them.
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Figure 8. Stratum lamellatum harvested from an equine hoof (a) and the resulting cell pellet
(b) after digestion, filtering and centrifugation.

Figure 9. Transmission electron photomicrographs of cultured progenitor cells from fresh (a)
and cryopreserved (b) equine stratum lamellatum. The cells from the cryopreserved tissue
show signs of senescence.
1.6. Transdifferentiation and regenerative medicine-scaffold
Transdifferentiation is a complex process by which immature cells assume a new lineage that
is distinct from their embryonic origin, parent tissue or current phenotype. [124] Numerous
distinct

and

overlapping

transdifferentiation.

Both

cell

signaling

mesodermal

pathways

and

have

epidermal

been

progenitor

associated
cells

with

possess

transdifferentiation abilities as alluded to above. In mice and humans bone marrow progenitor
cells can assume skin and neural phenotypes. [125, 126] Similarly, in horses, mesodermal
progenitor cells from horse bone marrow show neural crest-like cell morphology and
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expression of neural proteins after neural differentiation. A well-known transdifferentiation
process is epidermal to mesenchymal transition (EMT). Controlled EMT is a key process in
normal tissue healing, while uncontrolled EMT is characteristic of neoplasia. [127, 128] One
caveat raised by researchers is that transitional cells, or cells expressing proteins from
multiple lineages, must be thoroughly characterized to confirm their identity and avoid
confusion with cells that result from fusion of stem cells with somatic cells. [129-132]
Elucidation of the EMT process by hoof progenitor cells may provide novel insight to the
pathology of laminitis.
A natural interface between epidermis and dermis like that in human skin as well as equine
hoof stratum lamellatum would reasonably contain transitional progenitor cells that can
function in repair and maintenance of the complex tissue connection. [133] Recently, cells
that express epidermal, K15, or mesodermal, CD105, proteins were identified in the stratum
lamellatum. [119] Progenitor cell isolates that expressed both proteins were subsequently
isolated from heterogenous stratum lamellatum primary cell isolates and cultured through
multiple passages in vitro (Fig. 10). [116] The cells showed ectodermal and mesodermal
plasticity and transdifferentiation capabilities. The potential for EMT to contribute to
laminitis is suggested by the abundant mesodermal wedge of fibrous tissue typical of the
condition. This is especially notable given the presentation of transitional cells in the stratum
lamellatum. Inflammation has been shown to favor mesodermal tissue formation. [134] This
leads credibility to the potential for inflammatory cytokine driven EMT in inflamed hooves.
Given the potential for diverse neotissue formation, transitional progenitor cells may be a
meaningful therapeutic target to help avoid permanent tissue damage and restore normal
formation after an inflammatory insult in the equine hoof.

17

Figure 10. Transmission electron photomicrographs of P3 progenitor cells from equine hoof
stratum lamellatum cultured on culture ware (a) and on decellularized lamellar tissue matrix
(b). Gold-labeled secondary antibody labels (arrow) against K15 (10 nm) and CD105 (20 nm)
localize in cell cytoplasm (a) and on the fibrous construct (b).
Decellularized tissue matrix scaffolds are frequently used for in vitro and in vivo neotissue
formation because they provide structural support and a favorable environment that contains
various amounts of native tissue proteins to facilitate cell attachment and help guide
differentiation. [135, 136] The matrices can be derived from virtually any tissue and are
typically decellularized and partially deproteinized via chemical and thermal means in a
variety of combinations. [137, 138] However, the tissue matrix does not necessarily have to
come from the recipient species or tissue. Decellularized matrices have been used to support
regeneration of tissues from relatively simple musculoskeletal structures to complex organs
like liver. [139, 140]
The complicated skin structure requires a matrix framework that recapitulates or facilitates
formation of the epidermal-dermal junction during healing. Maturation of keratinocytes to
form the protective, outer layers of skin relies on a healthy connection between the epidermis
and dermis. [141] Synthetic and natural tissue matrices alone and with progenitor cells have
been used to augment skin healing, and collagen-based matrices are widely popular. [134] A
report details the use of porcine small intestinal submucosa matrix to treat granulating
wounds on horse distal limbs. [142] MSCs from equine umbilical cord-blood embedded in an
autologous fibrin gel were also found to improve the histologic outcomes of distal limb skin
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wounds. [143] Dextran-based hydrogel scaffold improves neovascularization and skin
regeneration in porcine burn wounds by promoting angiogenic cell infiltration and
accelerating healing kinetics. [144] Porcine burn wounds treated with collagenglycosaminoglycan scaffold-MSC constructs had significantly better healing than with
scaffold or cells alone. [145] While the hoof capsule has many differences from most of the
epidermis, the work above establishes strong precedent for tissue matrix and tissue matrixcell based therapies to restore normal hoof growth and repair.
Following severe inflammation, some changes in the basal membrane zone of the stratum
lamellatum include altered keratinocyte proliferation, loss or reduction of vital proteins like
laminin and collagen, and decreased cell hemidesmosome connections. Like other tissues,
there appears to be abundant progenitor cells in damaged tissue. However, lack of structural
and protein direction may prevent appropriate differentiation and, in fact, may misdirect
differentiation via EMT. It is possible that minimally invasive implantation of decellularized
stratum lamellatum (Fig. 11) or stratum lamellatum neotissue formed by progenitor cells
under controlled laboratory conditions may provide the necessary clues for restoration of
healthy hoof tissue. Continued in vitro research is necessary to advance and refine potential
administration of exogenous tissue or cell-tissue constructs.

Figure 11. Scanning electron micrograph of decellularized stratum lamellatum matrix
showing the typical lamellar structure (a, arrow) and the surface of the structure (b).
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1.7. The future of progenitor cell therapy
Progenitor cell therapy has gained substantial popularity over the last few decades. Potential
benefits of progenitor cells are abundant and include anti-inflammatory properties, direction
of endogenous cells, and acceleration of tissue healing or formation, among others. Current
Food and Drug Administration regulations, however, place strict regulations on preparation
and administration of primary cell isolates. Potential concerns about their use include lack of
a predictable half-life and route of elimination, the potential for undifferentiated cells to
assume pathologic phenotypes, and possible, dangerous immune reactions. Despite this,
promising results have been reported from primary cell administration. There are also
valuable options for cell use. Some include living tissue models that recapitulate normal and
abnormal embryonic tissue formation and generation of viable tissue grafts and organs for
implantation from autogenous or biocompatible autologous progenitor cells. It is conceivable
that neo-tissue models from hoof progenitor cells may provide a valuable resource for study
and treatment of equine laminitis. The ability to create live tissue models of the sensitive hoof
tissue will significantly advance its study. Culture conditions can be modified to replicate
normal, diseased, and inflamed tissues to evaluate and modify cell responses to withstand and
overcome tissue abnormalities from injury or systemic illness. In vitro neotissue models may
also result in viable tissue grafts and support development of custom therapeutic matrix for
local administration. Inherent to these futuristic, but theoretically attainable goal is the
continued need to isolate and fully characterize native progenitor cell populations. It is only
through focused, incremental advances that the infinite power of the cell can be harnessed to
restore normal function of an organ or system for the health and well-being of a whole
organism.
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CHAPTER 2. IN VITRO CHARACTERISTICS OF HETEROGENEOUS
EQUINE PROGENITOR CELL ISOLATES*
2.1. Introduction
Damage to an ectodermal-mesodermal interface like that in the equine hoof and human
fingernail bed can permanently alter tissue structure and associated function. The purpose of
this study was to establish and validate in vitro culture of primary progenitor cell isolates
from the ectodermal-mesodermal tissue junction in equine hooves, the stratum internum, with
and without chronic inflammation known to contribute to lifelong tissue defects. The
following were evaluated in hoof stratum internum cell isolates up to 5 cell passages (P):
expansion capacity by cell doublings and doubling time; plasticity with multi-lineage
differentiation and colony-forming unit (CFU) frequency percentage; immunophenotype with
immunocytochemistry, and flow cytometry; gene expression with RT-PCR; and
ultrastructure with transmission electron microscopy. The presence of K15 and K19 as well
as cluster of differentiation (CD)44 and CD105 was determined in situ with
immunohistochemistry. To confirm in vivo extracellular matrix (ECM) formation, cellscaffold (polyethylene glycol/poly-L-lactic acid and tricalcium phosphate/hydroxyapatite)
constructs were evaluated with scanning electron microscopy nine weeks after implantation
in athymic mice. Cultured cells had characteristic progenitor cell morphology, expansion,
CFU frequency percentage and adipocytic, osteoblastic, and neurocytic differentiation
capacity. CD44, CD105, K15, and K19 proteins were present in native hoof stratum internum.
Cultured cells also expressed CD44, CD105, K14, K15 proteins in addition to CD29, K19,
and desmogleins 1 and 3. Gene expression of CD105, CD44, K14, K15, sex determining
*This chapter previously appeared as [Qingqiu Yang, Vanessa Marigo Rocha Pinto, Wei
Duan, Erica E. Paxton, Jenna H. Dessauer, William Ryan and Mandi J. Lopez. “In vitro
characteristics of heterogeneous equine hoof progenitor isolates”. Frontiers in Bioengineering
and Biotechnology 7 (2019):155].
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region Y-box 2 (SOX2) and octamer-binding transcription factor 4 (OCT4) was confirmed in
vitro. Cultured cells had large, eccentric nuclei, elongated mitochondria, and intracellular
vacuoles. Scaffold implants with cells contained fibrous ECM nine weeks after implantation
compared to little or none on acellular scaffolds. In vitro expansion and plasticity and in vivo
ECM deposition of heterogeneous, immature cell isolates from the ectodermal-mesodermal
tissue interface of normal and chronically inflamed hooves are typical of primary cell isolates
from other adult tissues, and they appear to have both mesodermal and ectodermal qualities
in vitro. These results establish a unique cell culture model to target preventative and
restorative therapies for ectodermal-mesodermal tissue junctions.
The equine hoof is a complex anatomical structure that changed in size and shape as horses
evolved from a multiple to a single toe ungulate [146-148]. Within a keratinized hoof wall,
the last phalanx of the third digit is suspended by the stratum internum (lamellatum) [149], an
attachment that can be permanently and fatally disrupted by inflammation within the hoof
wall known as laminitis [110, 150-154]. Following damage, complex hoof architecture is
replaced with abundant, poorly organized tissue [155, 156], and current treatments to restore
normal tissue after disruption are largely unsuccessful [157].
Tissue formation in the stratum medium, the cornified tissue layer directly above the stratum
internum, results from basal cell proliferation in the coronary band [158] located at the
proximal aspect of the structure. The cells undergo maturation into partially, keratinocyte, or
fully, corneocyte, keratinized cells as they move downward from the basal layer. Cells on the
surface of the redundant, frond-like lamellae that constitute the ectodermal-mesodermal
tissues in the stratum internum are connected to each other to form tight cell junctions [53,
159]. As the ectodermal component of the tissue connected to the outer hoof wall grows
downward relative to the mesodermal component fixed to the boney third phalanx via
collagen fibrils, cells are thought to detach and reattach via controlled enzymatic activity,
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largely within the basement membrane between them [12, 158]. While cell growth and
maturation is well described for the cornified hoof tissue, the role of progenitor cells within
the stratum internum to production and maintenance of the deeper hoof tissues, those at the
ectodermal-mesodermal interface, are not well elucidated [29, 160].
Isolation and characterization of progenitor cells from the ectodermal-mesodermal tissue
niche of normal and inflamed, laminitic, hooves is necessary to advance understanding of cell
behavior and reparative capacity under normal and inflamed conditions. [161, 162]
Proliferating cells were identified in normal hoof lamellae with 5-bromo-2’-deoxyuridine
(BRdU) [158]. Additionally, epithelial progenitor cells in the lamellae were localized by K14
and transcription factor p63 expression [19, 34, 118, 163]. This information confirms that
progenitor cells exist within the normal stratum internum. Altered progenitor cell behavior
from disease and chronic inflammation disrupts tissue formation and healing in ectodermaldermal tissue interfaces like the periodontal membrane and fingernail bed [164-166]. A
mechanism to confidently isolate and culture hoof progenitor cells from the ectodermalmesodermal tissue niche of normal and chronically inflamed hooves will provide a useful
tool to evaluate mechanisms of cell damage and target therapies to prevent cell loss and
restore normal growth following injury, local disease or systemic pathology. The purpose of
this study was to establish and validate in vitro culture of progenitor cells from the stratum
internum of equine hooves with and without chronic inflammation.
2.2. Material and methods
2.2.1. Ethics statement
This work was funded in part by the Louisiana State University Equine Health Studies
Program (EHSP) and the United States Department of Agriculture (USDA).

23

2.2.2. Study design
Forelimbs from twenty two horses belonging to the University research herd, 14 unaffected
(U) and 8 with laminitis (L), were disarticulated at the metacarpophalangeal joint following
humane euthanasia for reasons unrelated to this study. Cells were isolated from the stratum
internum and progenitor cells selected by plastic affinity. Outcome measures included cell
expansion rate for cell passages (P) 1-3 (n = 5 U; n = 6 L), P1 trilineage differentiation (n = 3
U; n = 3 L), P0, 2 and 5 colony forming unit frequency (CFU, n = 4 U; n = 3 L) and cell
surface marker expression (n = 8 U; n = 7 L), hoof tissue immunohistochemistry (IHC) (n = 2
U; n = 1 L), immunocytochemistry (ICC) of P1 and 3 (n = 2 U; n = 2 L), P0, 2 and 5 gene
expression of CD44, CD105, K14, K15, octamer-binding transcription factor 4 (OCT4), and
sex determining region Y-box 2 (SOX2) (n = 4 U; n = 5 L) and transmission electron
microscopy (TEM) of P1 cell ultrastructure (n = 2 U; n = 2 L). Scanning electron microscopy
(SEM, n = 1 U) was used to assess extracellular matrix (ECM) deposition on polyethylene
glycol/poly-L-lactic acid (GA) and tricalcium phosphate/hydroxyapatite (HT) scaffolds
loaded with P3 cells 9 weeks after subcutaneous implantation in athymic mice (Table 1).
2.2.3. Radiographs
Hooves were cleaned with soap and water and any shoes removed. Lateral digital radiographs
were performed immediately after limb collection with a portable radiography unit (70 kVp,
4l mAs, MiKasa X-ray Co, Japan) following placement of a radiopaque wire (length: 76.2 cm;
diameter: 0.05 cm) on the dorsal midline of each hoof. A scale bar was included in
radiographs to calibrate software tools used to make measures on digital images (Adobe
Photoshop, version 5.5, Adobe Systems Inc., Seattle, WA). Dorsal rotation was quantified by
subtracting the distance between the distal inner hoof wall and the third phalanx (P3) from
the distance between the proximal hoof wall and P3 (Fig. 1) [167]. Sinking was the distance
between the proximal portion of the coronary band and the extensor process of P3.
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Table 2. Horse Information and Study Assays I
Age (year)

Condition

Gender

Breed

Outcomes
CFU

CD/DT

3

Unaffected

Gelding

Thoroughbred

X

X

8

Unaffected

Mare

Thoroughbred

X

X

2

Unaffected

Mare

Thoroughbred

X

X

4

Unaffected

Gelding

Thoroughbred

X

X

13

Unaffected

Mare

Quarter Horse

3

Unaffected

Gelding

Thoroughbred

14

Unaffected

Mare

Quarter Horse

9

Unaffected

Gelding

Tennessee

X

ICC

IHC

PCR

FC

X

X

TEM

X

X
X

X

X

X

X

X

Walker
X

7

Unaffected

Mare

Arabian

7

Unaffected

Gelding

Paint Horse

22

Unaffected

Gelding

Palomino

X

17

Unaffected

Mare

Paint Horse

X

X

10

Unaffected

Mare

Quarter Horse

X

X

15

Unaffected

Gelding

Quarter Horse

17

Laminitic

Gelding

Quarter Horse

4

Laminitic

Gelding

Thoroughbred

4

Laminitic

Gelding

Thoroughbred

X

19

Laminitic

Gelding

Thoroughbred

X

13

Laminitic

Mare

Quarter Horse

7

Laminitic

Gelding

Quarter Horse

17

Laminitic

Mare

Quarter Horse

6

Laminitic

Gelding

American

X

X
X

X

X

X

X

X

X

X

X

X

X
X

X

X
X
X

25

X

X

X

X

X

X

X

X

2.2.4. Tissue harvest
Within 2 hours of harvest, hooves were cleansed with alternating washes of 10% sodium
hypochlorite, sterile water and 0.1% chlorhexidine. With each lateral hoof surface gripped in
a vice, two parallel cuts through hoof wall to bone were made 2 cm apart on the dorsal
surface from coronary band to toe using a reciprocating saw and sterile blades (DC385,
Dewalt®, Towson, MD). The cornified stratum externum and stratum medium between the
cuts was elevated with a hoof nipper to expose the stratum internum. A square of
approximately 2×2 cm was extracted from the midpoint of the dorsal surface with a #20
scalpel blade. The tissue was rinsed with 0.01% chlorhexidine then soaked in phosphate
buffered saline (PBS, Hyclone, Logan, UT) containing 1% antibiotic solution (MP
Biomedical, Irvine, CA) for 15-30 minutes at room temperature.
2.2.5. Cell isolation and culture
In a sterile petri dish (NuncTM IVF petri dish, Thermo Fisher Scientific, Inc., Waltham, MA),
tissue was minced into 1×1 mm squares using a #10 scalpel blade and then transferred to 50
ml sterile tubes containing collagenase digest composed of 0.1% bovine serum albumin (BSA)
(Sigma-Aldrich, St. Louis, MO) and 0.1% collagenase type-1 collagenase (Worthington
Biochemical Corporation, Lakewood, NJ) in Dulbecco’s modified Eagle’s medium with
Ham’s F12 nutrient mixture (DMEM-Ham’s F12, Hyclone). Samples in digest at a 1:2 tissue
to digest (v/v) ratio were incubated at 37˚C for 2 hours with 3-dimensional agitation (5.5×g,
GyroTwister™ GX-1000, LabNet, Inc., Edison, NJ). Subsequently, the digest was passed
through a 100 µm followed by a 70 µm filter (Thermo Fisher Scientific) and then centrifuged
at 260×g for 5 minutes. The stromal vascular fraction (SVF) was resuspended in stromal
medium (DMEM-Ham’s F12, 1% antibiotic solution (MP Biomedical, Irvine, CA), 10%
characterized fetal bovine serum (VWR Life Science, Radnor, PA)) and cultured on 10 cm
culture plates (Corning Inc., Corning, NY). Medium was refreshed after 24 hours and then
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every 3 days until 80% cell confluence. For study purposes, seeding density (5×103 cells/cm2),
culture conditions (37˚C, 5% CO2), and plate confluence (80%) for cell detachment (0.05%
trypsin, Hyclone) and passage were conserved throughout unless otherwise indicated.
2.2.6. Colony forming unit frequency (P0, 2, 5)
Limiting dilution assays were used to determine progenitor cell CFU frequency percentage
by established methods [168]. Cells were added to a 48-well plate at 5×103, 2.5×103,
1.25×103, 6.25×102, 3.12×102, and 1.56×102 cells/well in individual columns (8 replicates per
cell number). After 7 days of culture in stromal medium, wells were rinsed with PBS and
fixed with 1% paraformaldehyde (Sigma-Aldrich) in PBS at room temperature for 20 minutes
followed by staining with 0.1% toluidine blue (Sigma-Aldrich) for one hour and a distilled
water rinse. Digital images were obtained with an inverted phase contrast microscope
(Olympus® CKX41SF, Japan) instrumented with a digital camera (Olympus DP21, Japan).
Positive wells contained 10 or more stained colonies. The CFU frequency was calculated as F
= e-x, where F = the ratio of negative to total wells, e = natural logarithm constant 2.71 and x
= CFU number per well. The CFU frequency was expressed as a percentage (1/CFU
frequency×100) [169, 170].
2.2.7. Cell doublings and doubling time (P1-3)
Cell expansion was quantified in 12 well plates (Nunclon®, Sigma-Aldrich) as previously
described [169]. Cell numbers were evaluated after 2, 4, and 6 days of culture using trypan
blue exclusion and a hemocytometer. Cell doublings (CD) and doubling time (DT) were
calculated as CD = ln(Nf /Ni)/ln(2) and DT = CT/CD where CT = culture time, Nf = final cell
number, and Ni = initial cell number.
2.2.8. Multi-lineage differentiation (P1)
Adipogenic, osteogenic and neurogenic differentiation was confirmed in cell isolates cultured
in 6 well plates (Thermo Fisher Scientific). Cells were cultured in stromal medium for 5 days
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to about 80% confluence followed by culture in induction medium. For adipogenesis, cells
were cultured in adipogenic induction medium (DMEM-Ham’s F12, 3% FBS, 1% antibiotic
solution, biotin (33 mmol/L), pantothenate (17 mmol/L), insulin (1 mmol/L), dexamethasone
(1 mmol/L), isobutylmethylxanthine (IBMX, 0.5 mmol/L), rosiglitazone (5 mmol/L) (TZD,
AK Scientific, Union City, CA), 5% rabbit serum (Invitrogen Corporation, Carlsbad, CA))
for 3 days followed by adipogenic maintenance medium (adipogenic medium without IBMX
or rosiglitazone) for 2 more days. To confirm lipid accumulation, cells were fixed for 2 hours
in 4% paraformaldehyde at room temperature and then stained with oil red O. To assess
osteogenesis, cells were cultured in osteogenic induction medium (DMEM-Ham’s F12, 10%
FBS, 1% antibiotic solution, β-glycerophosphate (1 mol/L), dexamethasone (20 nmol/L),
sodium 2-phosphate ascorbate (50 mg/mL)) for 14 days and then fixed with 70% cold ethanol
for 2 hours. Calcium in colonies was stained with 2% alizarin red in distilled water (pH 4.2)
for 15 minutes at room temperature and then rinsed with distilled water [171]. Cells were also
cultured in neurogenic pre-induction medium (DMEM, 10% FBS, 1 mM 2-mercaptoethanol)
for 2 days followed by neurogenic induction medium (DMEM, 5.5 mM glucose, 120 µM
indomethacin, 10% FBS, 3 µg/ml insulin, 300 µM IBMX) for 3 days. They were fixed with 1%
paraformaldehyde overnight and then blocked with 10% goat serum for 1 hour at 37◦C. Cells
were incubated with a mouse anti-microtubule-associated protein (MAP2) primary antibody
(1:250) for 2 hours at 37◦C. They were then incubated with anti-mouse immunoglobulin G
(IgG) secondary antibody labeled with Alexa Fluor 488 (1:1000) (Table 2) for 1 hour at room
temperature. Controls included cells cultured in stromal medium and induced cells incubated
with secondary antibody alone. Nuclei were stained with 4, 6-diamidino-2-phenylindole
(DAPI, 1 μg/ml) for 10 minutes followed by a distilled water rinse. Photomicrographs were
obtained with a camera (DFC480, Leica Microsystems, Germany) on a fluorescent
microscope (DM 4500b, Leica Microsystems).
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2.2.9. Immunohistochemistry (IHC), immunocytochemistry (ICC) (P1, 3)
IHC (fluorescent)-Fresh tissue was embedded in optimal cutting temperature compound
(OCT, Sakura Finetek Inc., Torrance, CA), solidified at -80°C, sectioned (5µm) with a
cryostat (Leica® CM1850, Sarasota, FL), and applied to slides (poly L-lysine coated, SigmaAldrich). Sections were blocked with 10% goat serum (Abcam Inc., Cambridge, MA) in PBS
for 1 hour at room temperature after rehydration in PBS for 10 minutes. Slides were
incubated with individual primary antibodies (CD29, CD44, K14, K19) (Table 2) diluted in
tris-buffered saline (TBS, 1:200) at 37oC for 2 hours, rinsed with PBS, incubated with antimouse IgG-Alexa Fluor 594 at 37oC for one hour in darkness, and then rinsed with PBS again.
Nuclei were stained with Hoechst’s dye (Biotium, Hayward, CA), for 10 minutes at room
temperature in darkness. Digital images were obtained with a fluorescent microscope (DM
4500b, Leica) equipped with a digital camera (DFC 480, Leica). Unstained tissue and
sections incubated with secondary antibody alone were included as control samples.
IHC (chromogen)-Formalin fixed sections of laminae (1×0.5×0.5 cm) were paraffin
embedded and sectioned (5 µm). Antigen retrieval was performed by incubating in citrate
buffer (pH 6) for 30 minutes at 80°C. Sections were rinsed in PBS and endogenous
peroxidase was blocked by incubation in 3% H2O2 for 30 minutes at room temperature.
Nonspecific binding of antibodies was blocked by incubation with 1% BSA (Sigma-Aldrich)
and 1% pre-immune serum (Abcam) in PBS for one hour at 37oC. Sections were then
immunostained with murine anti-human antibodies against K14, K15 or K19 (Table 2)
overnight at room temperature. After rinsing in PBS, sections were incubated with horse
radish peroxidase (HRP) conjugated anti-mouse IgG (DAKO EnVision, Dako, Carpinteria,
CA) for one hour at room temperature. Bound antibodies were then exposed with
diaminobenzidine/H2O2 staining for three minutes at room temperature. Slides were

29

counterstained with hematoxylin and digital images captured with a light microscope
(DM5000B, Leica) instrumented with a camera (DFC 480, Leica).
ICC
Cells were seeded on eight well multi-chamber slides (7×103 cells/well, Thermo Fisher
Scientific). At approximately 70% confluence, cells were fixed in 4% paraformaldehyde.
They were then permeabilized with 1.0% Triton-X100 (Sigma-Aldrich) in PBS for 10
minutes at room temperature before blocking with 10% goat serum (Abcam) and 2% BSA
(Sigma-Aldrich) in 1.0% Triton X-100. Cells were incubated with primary antibodies against
desmoglein (DSG) 1, DSG3, K15 and K19 (Table 2) diluted 1:200 in the blocking solution
above for 2 hours at 37˚C followed by goat anti-mouse IgG-Alexa Fluor 594 (1:1000, Table 2)
at room temperature for 2 hours in darkness. Nuclei were stained with 4, 6-diamidoino-2phenylindole (DAPI). Photomicrographs were obtained with a fluorescent microscope (DM
4500b, Leica) equipped with a digital camera (DFC 480, Leica).
2.2.10. Flow cytometry (P0, 2, 5)
Antibodies against K14, K15, K19, CD29, CD44 and MAP2 (Table 3) specific for equine
antigens or validated for equine cross reactivity were used to label cells for flow cytometry.
With the exception of MAP2, antibodies were were conjugated with FITC (FluoroTag TM
FITC conjugation kit, Sigma-Aldrich). Cell aliquots (105 cells) were suspended in 800 ul of 1%
BSA and 0.2% sodium azide in PBS containing 2 μl (200 ug/ml) of labeled antibody, and the
mixture was incubated at room temperature for 30 minutes in darkness. Incubation with
keratin antibodies was performed after cell permeabilization (Cytofix/CytopermTM kit, BD
Biosciences, San Jose, CA). Following incubation with antibodies, cells were rinsed with
PBS and fixed with 4% neutral buffered formalin. For MAP2 detection, cells were
additionally cultured with anti-mouse IgG-Alexa Fluor 633 (Thermo Fisher Scientific). Cell
fluorescence was quantified using a FACSCalibur flow cytometer (BD Biosciences, San Jose,
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CA) and CellQuest graphics software (BD Biosciences). Unlabeled cells and isotype controls
were included for all assays.
Table 3. Antibodies Used for Heterogeneous Equine Hoof Progenitor Cells
Antibody

Label

Description

Cross/

Host

Manufacturer

Catalog #.

Diluent

Mouse

BD
Biosciences

BS610468

PBS

Rat

EBiosciences

11044182

PBS

Mouse

Abcam Inc

Ab69772

PBS

Mouse

Abcam Inc

Ab7800

PBS

Mouse

Abcam Inc

Ab80522

PBS

Reactivity
CD29

N/A

Integrin β-1

Human,
Mouse,
Rat, Dog,
Chicken

CD44

FITC

Hyaluronic

Human,

Acid

Mouse

Receptor
CD105

PE

Endoglin

Human,
Pig

K14

N/A

Keratin 14

Human,
Rat,
Human

K15

N/A

Keratin 15

Human,
Cow, Rat,
Mouse

K19

N/A

Keratin 19

Human

Mouse

Abcam Inc

Ab7754

PBS

MAP2

N/A

Microtubule

Mouse,

Mouse

FisherScientific

13-1500

PBS

Protein

Rat

IgG

FITC

Anti-mouse

Mouse

Goat

Sigma-Alorich

F0257

PBS

IgG

Alexa Fluor 633

Anti-mouse

Mouse

Goat

FisherScientific

A-21052

PBS

IgG

Alexa Fluor 488

Anti-mouse

Mouse

Donkey

FisherScientific

A-21202

PBS

IgG

Alexa Fluor 594

Anti-mouse

Mouse

Goat

FisherScientific

R37121

PBS

DSG1

N/A

Desmoglein-1

Human

Mouse

Invitrogen

32-6000

TBS

DSG3

N/A

Desmoglein-3

Human

Mouse

Invitrogen

32-6300

TBS
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2.2.11. RT-PCR (P0, 2, 5)
Equine specific primers were designed for OCT4, SOX2, CD29, CD44, CD105, K15, DSG1
and DSG3 (Table 4). Cells were detached from culture ware with 0.05% trypsin (Hyclone),
rinsed with PBS and centrifuged at 260×g for 5 minutes. Total mRNA was isolated
(RNAqueous Micro Kit Ambion, Inc., Austin, TX). Potential DNA contamination was
removed by DNase I (Turbo DNA free, Ambion, Inc., Austin, TX) digestion. Samples were
reverse transcribed into complementary DNA (cDNA) using oligo (dT) primers and Moloney
Murine Leukemia Virus (M-MLV) reverse transcriptase (Sigma-Aldrich). Target gene
mRNA levels were quantified with qRT-PCR using SYBR Green technology (Thermo Fisher
Scientific) and an MJ Research Chromo4 Detector (Bio-Rad Laboratories, Hercules, CA).
Amplicons were sequenced to confirm target sequence amplification. The ΔCt values were
determined relative to the reference gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH).
Table 4. Primer Sequences Information for Heterogeneous Equine Hoof Progenitor Cells
Gene

Forward

Reverse

Accession No.

GAPDH

CAA TGA CCC CTT CAT TGA CC

GAA GAT GGT GAT GGC CTT TC

NM_001163856

SOX-2

CAG CTC GCA GAC CTA CAT GA

TGG AGTG GGA GGA AGA GGT A

XM_023623361

AGT GAGA GGC AAC CTG GAG A

XM_023624232

OCT4

TCG TTG CGA ATA GTC ACT GC

CD29

CCA TTG TTC ACG TTG TGG AG

TTG GCA AAT TCC CTT CTG TC

XM_023631884

CD44

CAG CAC CCC TGC GGA TGA CG

TGG TCT TGG GTG GGG CGA GT

XM_023653788

CD105

CCC CAA GAG TCA ACA CCA CT

GTT CGA GAC TGC AGG AGG AC

XM_003364144

K14

TAC GAG ACG GAG CTG AAC CT

TGG CCT CTC AGG CTA TTC AT

XM_001346198

K15

GTG GCT TTG GTG ACT TTG GT

GTC TCG GAT CTT CAC CTC CA

XM_005597407

2.2.12. In vivo extracellular matrix production (P3)
Scaffold carriers composed of polyethylene glycol/poly-L-lactic acid (60:40, GA) and
tricalcium phosphate/hydroxyapatite (40:60, HT) were fabricated by thermally induced phase
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separation as previously described [172]. P1 Equine laminar progenitor cells form U hooves
were cryopreserved in liquid nitrogen in custom medium (10% dimethyl sulfoxide, 10%
DMEM/F-12, 80% FBS) after being gradually cooled to -80oC (-1oC/minute, CoolCell®,
BioCision, Larkspur, CA). They were then culture expanded to P3 and loaded (6.3×103
cell/mm3) onto scaffolds (diameter: 10 mm; depth: 3 mm) for 2 hours at 70 rpm stirring in a
spinner flask (Bellco® Biotechnology, Newark, NJ) containing 120 ml of serum-free stromal
medium. Cells that remained in the medium were quantified to estimate the number of cells
on the scaffolds. Scaffolds without cells were treated identically to those with cells prior to
implantation. Six equal pieces of each scaffold were surgically implanted in the dorsal
subcutaneous tissues of 4 (n = 6 implants/mouse) male athymic mice (nu/nu, Charles River
Laboratories, Wilmington, MA). One mouse received six individual pieces of an HT cellscaffold constructs, a GA cell-scaffold constructs, an HT scaffolds only, or a GA scaffold
only.
For the implantation procedure, mice were premedicated with glycopyrrolate (0.02 mg/kg)
and butorphanol (0.5 mg/kg) and subsequently anesthetized with isoflurane on oxygen
delivered via a Baine circuit and mask. Following aseptic preparation, 6 skin incisions (5
mm) were created equidistantly along the dorsum extending from the scapula to the sacrum,
approximately 1 cm lateral to each side of the spine, and scaffolds were placed after minimal
blunt dissection. Subcutaneous tissues were closed with monocryl (Monocryl ®, Cornelia,
GA) and skin apposed with tissue glue (Sigma-Aldrich). Nine weeks after implantation,
explants were fixed with 2.5% glutaradehyde in 0.1M sodium carcodylate buffer, post-fixed
with 0.1% osmium tetroxide, and dehydrated in a series of ethanol-distilled water solutions.
After critical point drying, constructs were sputter coated with gold and imaged with a
scanning electron microscope at 15 kVP (FEI Quanta 200, Netherlands) [173].
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2.2.13. Transmission electron microscopy (P1)
Cells at 80% confluence were detached and centrifuged at 260×g for 5 minutes at room
temperature. Pellets (3×106 cells/pellet) were fixed with 1.6% paraformaldehyde, 2.5%
glutaraldehyde, 0.03% CaCl2 in 0.05M cacodylate buffer (pH 7.4), washed in 0.1M
cacodylate buffer supplemented with 5% sucrose and post fixed in 2% osmium tetroxide for
1 hour. They were washed with distilled water and incubated in a 1% water solution of tannic
acid for 1 hour. Following dehydration with propylene oxide in ascending ethanol
concentrations, pellets were embedded in Epon-Araldite (EMS, Hatfield, PA). Blocks were
sectioned (80-90 nm, Ultratome Leica EM UC7, Germany) and stained with 2% uranyl
acetate in maleate buffer and lead citrate. Images were generated with a digital camera
(Hamamatsu ORCA-HR, Japan) on an electron microscope (JEOL JEM 1011, Japan). All
reagents for electron microscopy were from the same source (Electron Microscope Sciences,
Hatfield, PA).
2.3. Results
2.3.1. Radiographs
Capsular rotation was 1.0 ± 1.4 mm (mean ± SEM) and 3.7 ± 1.7 mm, and distal descent 9.0
± 0.8 mm and 10.6 ± 3.7 mm in U and L hooves, respectively (Fig. 12).

Figure 12. Radiographs of an unaffected (A) and a laminitic hoof (B) demonstrating where
distances were measured to determine capsular rotation (1-2) and distal descent (3).
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2.3.2. Cell isolation and culture
Cell yield was 1.34×107 ± 1.25×106 and 1.70×107 ± 3.05×106 nucleated cells/g from U and L
hoof tissue, respectively. Primary cell isolates from all hooves exhibited a rhomboid shape
after 2 days of culture (Fig. 13 A, B). After one week’s culture, most cells from unaffected
and laminitic hooves had a typical spindle shape consistent with progenitor cell morphology
(Fig. 13 C, D).

Figure 13. Light photomicrographs of equine hoof progenitor cells from unaffected (A, C)
and laminitic hooves (B, D) after 2 (A, B) and 7 days (C, D) of culture. Bar = 500 μm

2.3.3. Colony forming unit frequency (P0, 2, 5)
The CFU frequency percentages tended to increase with increasing passage (Fig. 14). They
were 0.05% ± 0.04%, 0.17% ± 0.07% and 0.32% ± 0.31% for passages P0, 2 and 5,
respectively, for progenitor cells from U hooves. For the same cell passages from L hooves,
CFU frequency percentages were 0.20% ± 0.09%, 0.10% ± 0.06% and 0.41% ± 0.21%.
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Figure 14. Colony forming unit frequency percentages (mean ± SEM) for P0, 2, and 5
progenitor cells from unaffected and laminitic hooves.

2.3.4. Cell doublings and doubling time (P1-3)
The rate of in vitro expansion tended to increase with passage. Cell doubling values for P1,
P2 and P3 for cells from U hooves were 0.55 ± 0.65, 2.04 ± 1.20 and 1.58 ± 0.57 versus 0.85
± 0.50, 1.88 ± 1.10 and 1.99 ± 1.20 for the same passages from L hooves (Fig. 15 A).
Doubling times for P1, P2 and P3 cells from U hooves were 0.26 ± 0.15, 0.12 ± 0.07 and 0.20
± 0.11 days/CD versus 0.32 ± 0.19, 0.13 ± 0.07 and 0.12 ± 0.07 days/CD from L hooves (Fig.
4 B). Growth curve represented by cell numbers for P1, P2, P3 cells from U and L hooves as
well (Fig. 15 C).

Figure 15. Cell doublings (A), doubling times (B), growth curve with cell numbers (C) (mean
± SEM) for P1-3 progenitor cells from unaffected and laminitic hooves.
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2.3.5. Multi-lineage differentiation (P1)
Passage 1 progenitor cells from U and L hooves all displayed characteristic adipocytic (Fig.
16 A), osteoblastic (Fig. 16 B) and neurocytic (Fig. 16 C) differentiation following culture in
differentiation medium based on histochemical or immunocytochemical staining. Cells
cultured in stromal medium for identical time periods did not differentiate (Figs. 16 D-F).

Figure 16. Photomicrographs of P1 laminar progenitor cells cultured in adipogenic (A),
osteogenic (B), neurogenic (C) or stromal (D-F) medium and stained with oil red O (A, D),
alizarin red (B, E) or anti-map2, anti-mouse IgG-488 (green). DAPI nuclear stain (blue, C, F).
Magnification = 20X, Bar = 100 μm
2.3.6. Immunohistochemistry (IHC), immunocytochemistry (ICC) (P1, 3)
Both fluorescent (Fig. 17) and chromogen (Fig. 18) immunohistochemical labeling confirmed
the presence of CD44, CD29, K14 and K19 in the stratum internum of both U and L hoof
tissue. Based on immunocytochemical staining, P1 and 3 cultured cells from U and L hooves
expressed DSG1 and DSG3 (Fig. 19) as well as K15 and K19 (Fig. 20).
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Figure 17. Fluorescent photomicrographs of primary and secondary epidermal lamellae from
an unaffected hoof labeled with antibodies (red) against K14 (A), K19 (B), CD44 (C),
andCD29 (D). Control sections were stained only with secondary antibody (E). Nuclei were
stained with Hoechst nuclear dye (blue). PEL = primary epidermal laminae; SEL = secondary
epidermal laminae. Arrows = stained cells; Magnification = 40X, Bar = 50 μm

Figure 18. Light photomicrographs of lamellae from unaffected (A, B) and laminitic (C, D)
hooves labeled (brown) with antibodies against K14 (A, C) and K15 (B, D). PEL = primary
epidermal laminae; SEL = secondary dermal laminae; Arrow = labeled cells; Magnification =
40X (B, C, D), Bar = 50 μm; Magnificaton = 20X (A), Bar = 100 μm
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Figure 19. Fluorescent photomicrographs of cultured progenitor cells (P3) from unaffected (B,
D) and laminitic (A, C) hooves labeled (red) with anti- DSG1 (A, B) or DSG3 (C, D)
antibodies. Control cells were stained only with secondary antibody (E). Nuclei were stained
with DAPI (blue). Magnification = 40X

Figure 20. Fluorescent photomicrographs of cultured hoof progenitor cells (P1) from
unaffected (A, B) and laminitic (C, D) hooves after labeling (red) with antibodies against
K15 (A, C) or K19 (B, D). Control cells cultured with stromal medium were stained only
with secondary antibody (E). Nuclei were stained with DAPI (blue). Magnification = 20X
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2.3.7. Flow cytometry (P0, 2, 5)
Passage P0, 2 and 5 cultured progenitor cells from U and L hooves expressed CD29, CD44,
CD105, K14, K1 and K19 (Fig. 21). The percentage of cells expressing CD105 or CD44 (Fig.
21 B, C) tended to decrease with passage while the percentage expressing CD29 (Fig. 21 A)
remained fairly constant across passages. The majority of P2 and 5 from both hoof conditions
expressed K14, K15 and K19 (> 90%) (Figs. 10 D-F). Approximately 80% of cells cultured
in neurogenic induction medium expressed MAP2 compared to 18% of cells cultured in
stromal medium, and the peaks for unlabeled, stromal and differentiated cells had distinct
histogram peaks (Fig. 22).

Figure 21. Flow cytometry histogram showing MAP2 labelling of P1 equine hoof progenitor
cells from an unaffected hoof cultured in stromal (Stromal MAP2) or neurogenic medium
(Neurogenic MAP2), and autofluorescence of unlabeled cells cultured in neurogenic medium
(Neurogenic Auto, A). Percentage (mean ± SEM) of P1 hoof progenitor cells from unaffected
hooves expressing MAP2 after culture in stromal (Stromal) or neurogenic (Neurogenic)
induction medium.
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Figure 22. Flow cytometry histogram showing MAP2 labelling of P1 equine hoof progenitor
cells from an unaffected hoof cultured in stromal (Stromal MAP2) or neurogenic medium
(Neurogenic MAP2), and autofluorescence of unlabelled cells cultured in neurogenic medium
(Neurogenic Auto, A). Percentage (mean ± SEM) of P1 hoof progenitor cells from unaffected
hooves expressing MAP2 after culture in stromal (Stromal) or neurogenic (Neurogenic)
induction medium. Hoof progenitor cells from unaffected hooves expressing MAP2 after
culture in stromal (Stromal) or neurogenic (Neurogenic) induction medium.

2.3.8. RT- PCR (P0, 2, 5)
Gene expression of CD44, CD105, K14, K15, OCT4 and SOX2 by P0, 2 and 5 progenitor
cells from U and L hooves was confirmed (Fig. 23). Gene expression was relatively similar
between conditions and stable across passages. Exceptions included an apparent decrease in
K14 expression with increasing passage in cells from U hooves and an increase in CD44
expression with increasing passage in cells from L hooves. The stability of the reference gene,
GAPDH, was confirmed by a CT value of 17.71 ± 0.20 for all samples.
2.3.9. In vivo extracellular matrix production (P3)
Approximately 5.60×103 cells/mm3 were loaded onto each scaffold. Abundant collagen
fibrils and organized ECM was apparent on scaffolds containing cells (Fig. 24 A, B), while
those without cells contained fewer collagen fibrils and little organized ECM (Fig. 24 C, D).
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Figure 23. Expression levels (ΔCT, mean ± SEM) of CD44 (A), CD105 (B), K14 (C), K15
(D), OCT4 (E) and SOX2 (F) in progenitor cells from unaffected (U) and laminitic (L)
hooves at the indicated passages. Reference gene: GAPDH; SOX2 = SRY (sex determining
region Y)-box 2; OCT4 = octamer-binding transcription factor 4

Figure 24. Scanning electrophotomicrographs of scaffold constructs with (A, B) and without
(C, D) P3 equine hoof progenitor cells from an unaffected hoof 9 weeks after subcutaneous
implantation in athymic mice. Arrow = collagen fibrils; Arrowhead = organized extracellular
matrix; Magnification = 6000X (A, C); 3000X (B, D)

2.3.10. Transmission electron microscopy (P1)
Cell ultrastructure was similar between cells from U and L hooves. Large, irregular, eccentric
nuclei, elongated mitochondria, rough endoplasmic reticulum surrounded by cisternae, and
randomly distributed cytoplasmic vacuoles were present in all cells evaluated (Fig. 25).
42

Figure 25. Transmission electromicrographs of progenitor cells (P1) from normal (A, B) and
laminitic (C, D) hooves. Black arrow = vacuole; White arrowhead= nucleus; Black
arrowhead = mitochondria; White arrow = rough endoplasmic reticulum; Magnification =
10,000X (A, C), 20,000X (B, D)

2.4. Discussion
The work in this study establishes a reproducible mechanism to isolate and culture progenitor
cells from unaffected and chronically inflamed ectodermal-mesodermal tissue of the equine
hoof, a tissue interface similar to the human and mouse periodontal membrane and the human
fingernail [174, 175]. In vitro culture of adult progenitor cells provides a mechanism to
evaluate cell behavior under distinct conditions [176-179] to assess cell alterations mediated
by chronic inflammation or disease. The methods will support cell and tissue culture for
investigation of mechanisms to prevent or address pathogenic processes in ectodermalmesodermal tissue. This work establishes a unique an important model to study progenitor
cells in the distinct ectodermal-mesodermal niche, a site of important health challenges in
both veterinary and human patients [180, 181].
Plastic adherence of the cells in this study is consistent with cell immaturity and multilineage differentiation confirms plasticity [182-184]. Progenitor cells from both inflamed and
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unaffected tissues showed similar in vitro behavior as equine progenitor cells from normal
adult tissues [184-187], and characteristics appeared to be maintained through numerous
passages [188]. Notably, mesodermal and ectodermal cell differentiation suggests the
presence of cells from different lineages, cells capable of transdifferentiation, or, most likely,
both given the heterogenous composition of the isolates. In vitro expansion rates of about 0.3
days/CD in this study was slightly higher than those reported for bone marrow, adipose and
umbilical cord derived equine MSCs of about 1 day/CD [189] and human epidermal
keratinocytes of about 0.7 days/CD [190]. Distinct culture conditions and natural variation
typically contribute to differences in expansion behavior among studies [191, 192]. The CFU
frequency percentages in this study are comparable to those from mesodermal and
ectodermal equine progenitor cells of about 0.6% and 1.5%, respectively [79, 193]. Taken
together, these results confirm the immaturity of the heterogeneous primary cell isolates.
The presence of mesodermal and ectodermal proteins in hoof tissue and within heterogeneous
cell isolates in vitro is important to translate information between in vitro and in vivo
conditions [194-202]. A prominent goal of this series of investigations was to validate
parallel protein expression in cultured primary cell isolates and tissue. Despite a plethora of
methods to culture progenitor cells from numerous tissues of most species, localization of
progenitor cell antigens in situ and in vitro is rare [203, 204]. The fact that the cell isolates
retained their characteristics in culture based on flow cytometry results is especially vital to
the validity of the culture model. Results of this study are limited to cells that have been
passaged beyond the initial stromal vascular fraction isolate. Culture of cells under ideal
conditions can potentially mask natural attributes and behaviors, a recognized limitation of
cell culture and impetus to maintain culture conditions that replicate distinct natural states
[205].
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The ability of cells within heterogeneous primary cell isolates to mature into distinct lineages
in this study is consistent with current knowledge surrounding cell plasticity, especially in
tissue interfaces [206-208]. As indicated above, it is likely that the junction between
epidermal and dermal tissues contains progenitor cells from ectodermal and mesodermal
embryonic layers, and, potentially, transitional cells that have characteristics of both tissue
types permitting ready transdifferentiation [209]. Additional work is needed to isolate and
characterize specific cell immunophenotypes from heterogeneous primary cell isolates.
Tight cell junctions that stabilize the ectodermal-mesodermal tissue interface are composed
of a variety of proteins like desmogleins, cadherins, laminins and E-selectins, among others
[210]. Desmogleins are major proteins of desmosomes, cell to cell junctions [211], and
hemidesmosomes, cell to tissue or ECM junctions. Loss of desmoglein integrity or
diminished production is associated with sloughing of the epidermis [212-215] and abnormal
tissue production [216, 217]. There are fewer hemidesmosomes along the basement
membrane between the ectodermal and dermal layers in inflamed versus normal equine hoof
tissue [218]. Future studies using cell culture may further confirm the potential for disruption
of desmoglein function or production by inflammation.
The cells in this study shared some ultrastructural features with equine and human adult
multipotent cells including polymorphic nuclei, well-developed dilated cisternae of rough
endoplasmic reticulum, intracellular vacuoles and elongated mitochondria [219-223]. High
metabolic activity typical of immature cells is suggested by elongated mitochondria [224].
Intracellular vacuoles are associated with protein recycling [225, 226], and they are thought
to be filled with proteinaceous material destined for secretion in human adult stem cells from
bone marrow [227, 228]. There are also reports of small cytoplasmic vacuoles in Merkel cells
within canine whisker pad basal epidermis [229, 230]. The ultrastructure of the cells reported
here is consistent with high metabolic activity of progenitor cells and a secretory function
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typically associated with keratinizing cells [231]. The results are not consistent with any one
cell type and likely reflects heterogeneous nature of the cell isolates.
Abnormal tissue formation in inflamed ectodermal-mesodermal interface tissues has been
reported to be the result of altered maturation [203, 232-236]. As such, appropriate cell
direction is essential for stem cell transplantation therapies to drive restorative tissue
formation [237, 238]. The present study was not designed to assess treatment outcomes in
contrast to clinical reports of stem cell therapies [239, 240] or to compare characteristics of
cells from normal and inflamed tissue, but to establish a model of cell culture that
accommodates cells from both tissue conditions. Robust, organized ECM formation by hoof
progenitor cells on scaffold carriers confirms the translational potential of the cell isolates
from this study [241] comparably to published information[242]. However, future work is
necessary to formulate scaffold carriers to direct hoof progenitor cell differentiation in vivo or
support hoof tissue formation in vitro to create implantable graft tissue that guides native
progenitor cells [243, 244]. Evaluation of the broad cell signaling pathways represented by
OCT4 and SOX2 in primary cell isolates cultured under conditions that replicate native tissue
may be natural starting points for study of mechanisms to modulate cell behaviors in tissue
constructs [245-248]. In the future, de novo tissue formation with progenitor cells may
provide a new therapeutic option for chronic conditions of the ectodermal-mesodermal
interface.
The authors recognize several limitations of this preliminary study to establish isolation and
culture of progenitor cell isolates from an ectodermal-mesodermal interface. Cell isolates are
heterogeneous, so work is necessary to isolate and evaluate unique progenitor cell
immunophenotypes given that characteristics of a cell population reflect but are not identical
to those of individual cells [249]. Also, as pointed out above, the initial 2D cell culture in
mesodermal basal medium as well as the isolation process very likely selected for distinct
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progenitor cell populations that may have stronger mesodermal than ectodermal predilections
[222, 250, 251]. Selection of cell immunophenotypes and subsequent culture in mesodermal
and ectodermal basal medium will provide important information about the novel progenitor
cells residing in the ectodermal-mesodermal interface. Nonetheless, the presence of
mesodermal and ectodermal antigens and differentiation potential over multiple cell passages
confirm that cells of both embryonic origins survived under the culture conditions employed
in this study.
Progenitor cell isolates from the ectodermal-mesodermal tissue interface of the equine hoof
display characteristics of both tissue types and maintain progenitor qualities through multiple
in vitro cell passages. The cells are present in both normal and inflamed tissue and key
protein antigens, including those in cell to cell and cell to tissue junctions, are retained in
culture. Hoof progenitor cells promote collagenous extracellular matrix formation on distinct
scaffold carriers in vivo, confirming future opportunities for cell directed tissue formation.
Results from this study set the stage for work to ascertain mechanisms by which
inflammation impacts progenitor cells in the ectodermal-mesodermal niche. Methods to
direct appropriate cell differentiation and tissue formation will provide new therapeutic
approaches to inflammatory conditions of tissue interfaces.
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CHAPTER 3. ULTRASTRUCTURAL MORPHOLOGY IS DISTINCT
AMONG PROGENITOR CELLS ISOLATES FROM NORMAL,
INFLAMED AND CRYOPRESERVED EQUINE HOOF TISSUE AND
CD105+K14+ PROGENITOR CELLS*
3.1. Introduction
The equine hoof dermal-epidermal interface requires progenitor cells with distinct
characteristics. This study was designed to provide accurate ultrastructural depictions of
progenitor cells isolated from inflamed tissue and normal tissue before and after
cryopreservation and following selection of cells expressing both K14 (ectodermal) and
cluster of differentiation (CD) 105 (mesodermal). Passage 3 cell ultrastructure was assessed
following 2D culture and after 3D culture on decellularized hoof tissue scaffolds. Outcome
measures included light, transmission electron, and scanning electron microscopy, and
immunocytochemistry. Cells from normal tissue had typical progenitor cell characteristics.
Those from inflamed tissue had organelles and morphology consistent with catabolic
activities including lysosomes, irregular rough endoplasmic reticulum and fewer vacuoles
and early endosomes than those from normal tissue. Cryopreserved tissue cells appeared
apoptotic with an irregular cell membrane covered by cytoplasmic protrusions closely
associated with endocytic and exocytic vesicles, chromatin aggregated on the nuclear envelop,
abundant, poorly organized RER and plentiful lysosomes. Cells that were K14+, CD105+
were distinguishable from heterogenous cells by infrequent microvilli on the cell surface,
sparse endosomes and vesicles, and desmosomes between cells. Cells expressed ectodermal
(K15) and mesodermal (CD105) proteins in 2D and 3D culture. Inflamed and cryopreserved
tissue isolates attached poorly to tissue scaffold while normal tissue cells
* This chapter previously appeared as [Qingqiu Yang and Mandi J. Lopez. “Ultrastructure
morphology is distinct among progenitor cell isolates from normal, inflamed, and
cryopreserved equine hoof tissue and CD105+K14+ progenitor cells” In Vitro Cellular &
Developmental Biology-Animal 9 (2019): 1-15].
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attached well, but only K14+, CD105+ cells produced extracellular matrix after 4 days. The
ultrastructural information provided by this study contributes to understanding of equine hoof
progenitor cells to predict their potential contributions to tissue maintenance, healing and
damage as well post-implantation behavior.
The equine hoof originates from a dermo-epidermal anlage to form what is considered one of
the most complex mammalian integumentary structures [252]. A branched, interdigitating
interface between the epidermal and dermal layers, the lamellar stratum internum, suspends
the bony third phalanx from the cornified hoof capsule [146, 149]. The interface both
withstands the physiologic forces of ambulation and participates in hoof tissue homeostasis
[253]. The unique tissue architecture composed of redundant, dermal and epidermal tissue
extensions creates an expansive surface area with innumerable cell tight junctions within
minimum volume. Inflammation of the stratum internum, laminitis, has severe consequences
on the tissue’s structural integrity and can cause permanent disfigurement and compromised
function [254, 255].
Ultrastructural features are invaluable to understanding cell activities, interactions, and
identity, as well as the consequences of pathology [256, 257]. Ultrastructure of the stratum
internum, including desmosome cell junctions and a basement membrane interface between
epidermis and dermis is described [12, 258] as are pathologic changes in post-mortem
samples from naturally occurring and artificially induced inflammation [53, 55]. However,
viable, cultured hoof cell morphology is vitally important to understanding both normal and
pathologic behavior and signaling. To date, ultrastructural evaluation of the cellular
component of the lamellar tissue interface is largely unexplored [34].
Knowledge about cells that occupy the unique dermal-epidermal niche are primarily limited
to human skin and nail bed, and there is a dearth of information about those cells that reside
in the same interface within the equine hoof. Transitional progenitor cells that share features
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of the transitional epithelium exist among basal cells at the squamous-columnar junction in
the mouse upper gastrointestinal tract [259]. The cells are thought to play a central role in
tissue maintenance, including the basement membrane of the dermal-epidermal junction
[253]. Comprehensive ultrastructural information is needed to fully elucidate the progenitor
cell population of the equine hoof dermal-epidermal interface.
A notable consideration for contemporary progenitor cell biology is the challenges of
distance and associated time between tissue harvest and processing sites. Cryogenic tissue
and/or cell preservation are frequently required [260]. Cryopreservation is known to alter the
behavior and morphology of progenitor cell isolates [121], though surrounding tissues are
thought to provide some protection to cells in vessel and bone tissue during stasis [261, 262].
Direct comparison of cell isolates from fresh and cryopreserved tissue helps predict
morphologic changes manifest by cryogenic preservation.
Decellularized tissue templates that provide a natural tissue niche to instruct exogenous
progenitor cells are popular for de novo tissue generation [263, 264]. The quantity and
organization of extracellular matrix produced by progenitor cells on tissue templates is often
used to discern cell neotissue forming capabilities [265]. Cell-scaffold interactions that drive
matrix deposition, composition and organization vary among cell morphologies as evidenced
by unique responses among progenitor cells from different tissues to identical decellularized
scaffold [266-269]. Behaviors also vary between cells from normal and inflamed tissues
[270]. Additionally, a strong predictor of progenitor cell potential for functional tissue
formation is preservation of characteristics in both 2D and 3D culture [205]. As such,
evaluation of hoof progenitor cell behavior on decellularized laminar tissue provides a natural
foundation for de novo hoof tissue generation and anticipation of in vivo behavior [267].
Recent studies support the promise and potential of progenitor cells to contribute to and
direct bone tissue formation in vitro and in vivo [271, 272]. Differences among species,
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progenitor cell tissue sources, and freezing techniques preclude assumptions or predictions
about progenitor cells without explicit evaluation [273, 274].
This series of investigations provides essential details about the in vitro ultrastructure of
equine hoof progenitor cells from normal, inflamed, and cryopreserved tissue. The
ultrastructure of a novel transitional progenitor cell immunophenotype is also presented.
Potential for generation of 3-D cell-tissue template constructs is explored by ultrastructural
assessment of cultured progenitor cells of each description on decellularized stratum
internum tissue templates. In all, the objective of the work is to provide novel and accurate
depictions of progenitor cells isolated from the unique dermal-epidermal niche of equine hoof
tissue exposed to distinct and meaningful conditions.
3.2. Materials and methods
3.2.1. Ethics statement
This study is supported by the Louisiana State University Equine Health Studies Program
(EHSP) and United States Department of Agriculture (USDA).
3.2.2. Tissue harvest
Cells were harvested immediately post-mortem from 6 horses (Table 1) with and without a
history of chronic laminitis that were humanely euthanized for reasons unrelated to this study.
Briefly, following aseptic preparation of the hoof surface, the stratum internum was exposed
by elevation of the cornified hoof wall between two parallel, full thickness cuts
(approximately 6 cm apart) extending from proximal to distal on the dorsal hoof. Two
contiguous regions of stratum internum (2 x 2 cm) were sharply excised with a sterile #20
scalpel blade, and, following a rinse with 0.01% chlorhexidine, maintained in phosphate
buffered saline (PBS, HycloneTM, Logan, UT) containing 1% penicillin at 4˚C for
approximately 1 hour. One sample was then placed in 1 ml cryopreservation medium (10%
dimethyl sulfoxide (DMSO), 10% Dulbecco’s modified Eagle’s medium with Ham’s F12
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nutrient mixture (DMEM-Ham’s F12, Hyclone, Logan, UT), 80% fetal bovine serum (FBS,
VWR Life Science, Radnor, PA)) within a microvial (Fisher Scientific, Denmark), and
cooled to -80˚C at which they there maintained for one week (CoolCellTM LX, BioCision,
Tewksbury, MA).
3.2.3. Cell isolation and culture
Cryopreserved tissue was thawed at room temperature for 5 minutes and washed three times
with PBS to remove cryopreservation medium. Fresh and thawed tissue was diced into cubes
(5 mm x 5 mm) and added to 50-ml sterile tubes containing 0.1% collagenase digest (0.1%
bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO), 0.1% collagenase type-1
(Worthington Biochemical Corporation, Lakewood, NJ) in DMEM-Ham’s F12 medium) at a
ratio of 1:2 tissue to digest (v/v). Digests were maintained at 37˚C for 2 hours with 3dimensional agitation (5.5 ×g, GyroTwister™ GX-1000, Labnet, Inc., Edison, NJ). The
mixture was passed through a 100-µm followed by a 70-µm filter (Fisher Scientific, Waltham,
MA) and centrifuged at 260 ×g for 5 minutes. Cell pellets were suspended in stromal culture
medium (10% FBS, 1% antibiotics in DMEM-Ham’s F12 medium) and cells seeded on 10
mm tissue culture plates (Fisher Scientific, Denmark) at a density of 5x103 cells/cm2.
Medium was refreshed every three days and cells were passaged at 80% confluence
following trypsin (Hyclone, Logan, UT) detachment and hemocytometer quantification.
Standard culture conditions were used (5% CO2, 37◦C).
3.2.4. CD105+, K14+ cell isolation
Cells from fresh tissue were incubated with polyclonal antibodies, labeled CD105-PE (Mouse,
eBioscience # 12-1057-42, San Diego, CA) and unlabeled K14 (Mouse, Fisher Scientific, #
MA5-11599, Rockford, IL) to which a dylight 633 label (Fischer Scientific) was added, at a
concentration of l μl (0.2 μg) /1x106 cells in darkness for 40 minutes. Cells expressing both
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antibodies were selected with a FACSCalibur flow cytometer and Cell Quest Pro software
(BD Biosciences, San Jose, CA).
3.2.5. Cell cytoskeleton morphology
Cells were added (5x103 cells/cm2) to 6-well culture plates (Fisher Scientific, Denmark) and
cultured in stromal medium for 7 days. Following three rinses with PBS, cells were fixed in 4%
paraformaldehyde at 4˚C overnight. Plates were rinsed with PBS and cells were
permeabilized with 1% Triton-x100 for 20 minutes at room temperature followed by
incubation with Actin-stainTM488 phalloidin (2 mg/ml, 1:150, # PHDG1-A, Cytoskeleton Inc.,
Denver, CO) according to the manufacturer’s instructions. Nuclei were stained with Hoechst
33342 dye (10 mg/ml, 1:1000, # H1399, Invitrogen, Carlsbad, CA) and results were viewed
with a fluorescent microscope (DM5000B, Leica, Buffalo Grove, IL) fitted with a digital
camera (DFC 480, Leica).
3.2.6. Transmission electron microscopy ultrastructure
Megascopic cell pellets (3x106 cells) formed by centrifugation (260 ×g, 5 minutes) with cells
detached as described above were fixed in 1.6% paraformaldehyde, 2.5% glutaraldehyde, and
0.03% CaCl2 in 0.05M cacodylate buffer (pH 7.4) overnight. Following a 0.1M cacodylate
buffer wash, post-fixation was performed with 2% osmium tetroxide for 1 hour, a distilled
water wash, and incubation in 1% tannic acid for 1 hour. Cell dehydration was performed
with propylene oxide in an ascending ethanol series followed with Epon-Araldite (EMS,
Hatfield, PA) embedding. Blocks were sectioned (80-90 nm, Ultratome Leica EM UC7,
Germany) and stained with 2% uranyl acetate in maleate buffer and lead citrate for 5 minutes.
An electron microscope (JEOL JEM 1011, Japan) with a digital camera (Hamamatsu ORCAHR, Japan) was used for imaging.

53

3.2.7. Transmission electron microscopy immunolabeling
Pellets of K14+, CD105+ cells prepared as described above and cell constructs (described
below) were fixed in 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1M phosphate
buffer (PB) for 10 minutes. Samples were centrifuged (260 ×g, 5 minutes), the supernatant
removed and replaced with fresh fixative, and then samples maintained on an orbital shaker
(Fisher Scientific, Canada) at room temperature for 2 hours. Following removal of the
supernatant, pellets were combined with an equal volume of 3% agarose and cut into cubes
following solidification. Cubes were placed into glass vials containing 0.1M phosphate
buffer, pH 7.4, washed with 0.1M phosphate buffer and 0.08M glycine 5 times for 15
minutes, and then washed with distilled water 3 times for 5 minutes.
Samples were dehydrated in 100% ethanol 3 times for 20 minutes each. They were then
infiltrated with 100% ethanol and London resin (LR) white (1:1) for 2 hours at room
temperature followed by 2 hours of soaking in fresh 100% LR white. Samples were
embedded in 100% LR white in a beam embedding capsule and polymerized at 65˚C for 24
hours. Ultra-thin sections (90 nm, Leica EM UC7 Microtome) were collected on a 150-mesh
filmed carbon coated nickel grid (EMS FCF-150-Ni). They were blocked with 5% bovine
albumin (Sigma, St. Louis, MO) in PBS for 30 minutes, incubated with a K15 polyclonal
antibody (rabbit, 0.2 mg/ml, 1:100, Proteintech, # 10137-1-AP, Rosemont, IL) in a buffer
containing 1X phosphate buffered saline with tween 20 and 0.2% BSA-c (pH 7.4) for 4 hours
at 4˚C, and then washed 6 times with buffer, each time 5 minutes. Sections were incubated
with a gold conjugated secondary antibody (anti-rabbit IgG, 0.15 mg/ml, 1:20, 10 nm,
Cytodiagnostics, # AC-100105, Canada) in buffer for 90 minutes at room temperature
followed by a rinse with buffer as before. The same sections were incubated with a CD105
antibody (mouse, 0.2 mg/ml, 1:10, eBioscience, # 12-1057-42, San Diego, CA) in buffer
overnight at 4˚C. Sections were washed with buffer 6 times for 5 minutes, followed by
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another wash in phosphate buffered saline with Tween 20 for 3 times, each time 5 minutes.
They were then incubated with a gold conjugated secondary antibody (anti-mouse IgG, 0.15
mg/ml, 1:20, 20nm, Cytodiagnostics, # AC-200205, Canada) in buffer for 120 minutes at
room temperature followed by 6 buffer rinses, 5 minutes each. Samples were post-fixed in
2% glutaraldehyde in PBS for 5 minutes. Sections were washed thoroughly in distilled water
and stained with 2% uranyl acetate and lead citrate. Digital images were recorded as above.
3.2.8. Stratum internum tissue decellularization
Stratum internum tissue (5 x 5 x 5 mm) harvested as described above, was soaked in 0.1%
EDTA in PBS at room temperature for one hour, then in PBS alone for another hour. Tissue
was subsequently placed in 10mM tris (hydroxymethyl) aminomethane and 0.1% EDTA in
distilled water overnight at 4˚C. Samples were transferred to PBS for one hour at room
temperature and then to 10 mM tris (hydroxymethyl) aminomethane with 0.5% SDS in
distilled water for 24 hours at 4˚C. They were washed with PBS three times for 5 minutes and
then soaked in 4M ice-cold perchloric acid for 30 minutes. Samples were moved into PBS for
1 hour and then lyophilized (-55˚C, VirTis BenchTop, Stanford, TX) for 12 hours.
Lyophilized tissues were sterilized with ethylene oxide prior to addition of cells.
3.2.9. Cell construct preparation and culture
Cell pellets were prepared as described above and then resuspended in 200 μl of PBS. A total
of 3x106 cells were added to stratum internum tissue scaffolds by pipetting to give a cell
density of 2.4x104/mm3. Constructs were cultured in 12 well plates (Fisher Scientific,
Denmark) with stromal medium for a total of 4 days under standard culture conditions (5%
CO2, 37◦C).
3.2.10. Construct ultrastructure with scanning electron microscopy (SEM)
Representative samples from each construct were fixed with 2.5% glutaraldehyde in 0.1 M
sodium carcodylate buffer (pH 7.4), post fixed in 0.1% osmium tetroxide, and dehydrated in
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a series of ethanol-distilled water solutions. They were sputter coated with gold and imaged
with an electron microscope (FEI Quanta 200, Netherlands) with a digital camera (Gatan
Orius SC1000A1, UK).
3.3. Results
3.3.1. Cell cytoskeleton morphology
Heterogeneous and CD105+, K14+ progenitor cell isolates had typical spindle shaped
morphology with minimal cell clustering. Heterogenous cell isolates from inflamed tissue
and isolates from cryopreserved, normal tissue had spindle-shaped morphology, but cells
tended to aggregate in culture (Fig. 26).

Figure 26. Passage 3 progenitor cells from fresh normal (A), inflamed (B), and cryopreserved
normal tissue (C), as well as CD105+, K14+ cells from fresh normal tissue (D) with
cytoskeletal (Actin-stainTM488, green) and nuclear (Hoechst dye, blue) staining.
3.3.2. Transmission electron microscopy ultrastructure of unsorted normal cells
There were distinct differences in ultrastructure among cell source environments. Progenitor
cells from fresh normal tissue contained eccentric nuclei with typical euchromatin and
closely approximated Golgi apparatus as well as abundant, cytoplasmic endosomes that were
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often surrounded by mitochondria and rough endoplasmic reticulum (RER) (Fig. 27). Cell
shape ranged from cuboidal to round with a relatively smooth surface. Cells contained
multiple early and late endosomes, elongated mitochondria as well as large vacuoles. Early
endosomes appeared as small, single compartment, membrane-bound vesicles. Late
endosomes, also known as multivesicular bodies, had intraluminal vesicles, and tended to be
larger than early endosomes. Vacuoles tended to be large and contents varied widely from
vesicle remnants to proteinaceous and particulate material, sometimes within intraluminal
vesicles and fused with early endosomes.

Figure 27. Heterogeneous progenitor cell isolates from normal hooves. Cells typically
contained a large eccentric nucleus (N) filled with euchromatin and surrounded by Golgi
apparatus (white black arrow with G). Multiple, cytoplasmic, late (large black arrows with
white outline) and early (small black arrows) endosomes were typically surrounded by
normal (gray arrowhead) and elongated (gray arrows, white outline) mitochondria and RER.
Abundant large vacuoles (V) had variable contents including particles (small white arrow
with P) and intralumenal vesicles (small black arrow with I) and were sometimes fused with
early endosomes (white arrowhead).
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3.3.3. Transmission electron microscopy ultrastructure of unsorted cells from fresh
inflamed tissue
Cells from fresh inflamed hooves tended to be aggregated in thin sections similar to
microstructural organization, and there were dead cells in various stages of degradation
among viable cells (Fig. 28). The cell shape was comparable to that of cells from healthy
tissue, but the surface was covered with shallow invaginations. Cells had large, irregular
nuclei with large clefts in the nuclear envelope and contained lysosomes with darkly stained
acidic content. Endosomes tended to be smaller and less abundant than those in cells from
healthy tissue, clustered, and surrounded by mitochondria and irregular RER. Small coated
vesicles were also around mitochondria. Large vacuoles were less frequent than in cells from
healthy tissue. Mitochondria around vacuoles tended to be elongated.
3.3.4. Transmission electron microscopy ultrastructure of unsorted cells from
cryopreserved normal tissue
Progenitor cells from cryopreserved normal tissue were characterized by dense, exocytic
vesicles, and an irregular cell membrane covered with cytoplasmic protrusions and microvilli
on the outer surface and endocytic vesicles on the inner surface. The cell cytoplasm was
electron-dense and amorphous. Cell organelles consisted primarily of poorly organized RER,
lysosomes with darkly stained material, small vacuoles with proteinaceous material, and
endocytic vesicles. Large nuclei contained aggregated chromatin close to the nuclear
membrane. Nonviable cells in various stages of degradation were present among viable cells
(Fig. 29).
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Figure 28. Progenitor cells from inflamed (laminitic) equine hooves. Nonviable cells (large
black arrows, white outline) were apparent among viable cells that had an irregular surface
and large nuclei (N) with deep membrane clefts. Cells contained lysosomes (large white
arrows, black outline) with dark staining acidic content. Vacuoles (V) and early endosomes
(small white arrow) were less prevalent than in cells from normal tissues. Endosomes were
surrounded by irregular RER and mitochondria (grayarrows, white outline). Small coated
vesicles (white arrow head) were often present around mitochondria. Late endosomes that
often contained single, large intralumenal vesicles (small black arrow) were also found
around early endosomes.
3.3.5. Transmission electron microscopy ultrastructure of unsorted cells from normal
fresh tissue
Cells from normal fresh tissue that were CD105+, K14+ were typically cuboidal and
had infrequent microvilli on the cell surface (Fig. 30). Nuclei were large with euchromatin
and prominent nucleoli. Endosomes and vesicles were infrequent, but those present were
surrounded by mitochondria and RER. Desmosomes were frequently present between cells.
Cells contained multivesicular bodies as well as small coated vesicles from early endosomes
around RER and mitochondria. Mitochondria close to the nucleus and had an elongated
morphology.
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Figure 29. Progenitor cells from cryopreserved normal laminar tissue. The irregular cell
membrane was covered by cytoplasmic protrusions and microvilli (large black arrows) that
were closely associated with endocytic vesicles (small black arrows with E) and exocytic
vesicles (white arrowhead). Nonviable cells (black arrow head) were present among viable
cells. Chromatin was aggregated on the nuclear envelop (large white arrows). Dark stained
lysosomes (small white arrow), small vacuoles (small black arrows) containing proteinaceous
material, and multivesicular bodies were present (gray arrows, white outline) and surrounded
by abundant, poorly organized rough endoplasmic reticulum (white circle).
3.3.6. Transmission electron microscopy immunolabeling (K15, CD105)
Gold particle labeled secondary antibodies to K15 (10 nm) and CD105 (15 nm) localized
singly or together in the cytoplasm of sorted cells (CD105+and K14+) and sometimes in close
proximity to the cell membrane (Fig. 31). There was no labeling in cells exposed to
secondary antibodies alone (Fig. 31D).
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Figure 30. Double positive (CD105+, K14+) progenitor cells from normal equine hoof tissue.
Cells had a large nucleus (N), infrequent microvilli (large black arrow, white outline) on the
surface, and sparse, large vacuoles (V). Multivesicular bodies (small black arrows) and
endocytic vesicles (large white arrows, black outline) were present among mitochondria
(gray arrow head) and RER. Desmosomes were present (small white arrows) between cells.
Elongated mitochondria (gray arrows) and non-elongated mitochondria (gray arrow head)
close to the nucleus were surrounded by small coated vesicles (white arrow heads).

Figure 31. Gold-labeled secondary antibodies against K15 (10 nm) and CD105 (20 nm) in
equine laminar progenitor cells from normal hooves sorted by co-expression of K14 and
CD105 antigens. Gold labels (black arrows) localized throughout the cell cytoplasm (A, B)
and in close proximity to the cell membrane (C), both singly and together. There was no
labeling of cells treated only with gold-labeled secondary antibodies (D).
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3.3.7. Construct ultrastructure (no cell control)
The primary and secondary epidermal lamellae structures were retained following
decellularization, but they were devoid of extracellular matrix and cells (Fig. 32).

Figure 32. Decellularized hoof stratum internum. The primary (black arrow, B) and
secondary (white arrows, B, C) epidermal lamellae architecture was retained during the
decellularization process, but it was devoid of extracellular matrix and cells.
3.3.8. Construct ultrastructure (with cells)
Cultured cells from fresh normal and laminitic tissue, from cryopreserved normal tissue, and
K14+, CD105+ cells from fresh normal tissue attached to decellularized scaffold after 4 days
of static culture in stromal medium (Fig. 33). There were abundant cells in all samples except
those from cryopreserved tissues which were present in scarce clusters. The cells from
laminitic tissue were also arranged in clusters, and cells from both had a round shape. Neither
had detectable extracellular matrix around the cells. In contrast, cells from normal tissue were
flattened and tightly adhered to the scaffold surface, and double positive cells were well
adhered and embedded in early, fibrous extracellular matrix.
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Figure 33. Scanning electrophotomicrographs of equine hoof progenitor cells on
decellularized stratum internum tissue scaffolds after 4 days of static culture in stromal
medium. Progenitor cells from normal tissue were strongly attached to the scaffold (A, E
white arrows). Progenitor cells from inflamed tissue had a round shape and were present in
clusters (B, F white arrows). Cells from cryopreserved tissue appeared in scarce clusters were
round (C, G, white arrows). Double positive cells (K14+, CD105+) were well attached to the
tissue scaffold (D, H white arrows) and surrounded by fibrous extracellular matrix (H, black
arrow).
3.3.9. Construct ultrastructure with transmission electron microscope double
immunostaining
Cell constructs with double positive sorted cells (CD105+and K14+) contained ectodermal
and mesodermal protein antigens after 4 days of culture based on localization of gold labeled
secondary antibodies K15 (10 nm) and CD105 (20 nm) in construct sections both together
and separately (Fig. 34).
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Figure 34. Construct sections demonstrating labeling of K15 (10 nm) and CD105 (20 nm)
protein antigens in decellularized epidermal stratum interim following four days of culture
with K14+, CD105+ hoof progenitor cells in stromal medium (A, B, black arrows). There was
no labeling of decellularized tissue without cells (C, D).

3.4. Discussion
The results of this study clearly demonstrate important distinctions in progenitor cell
morphology among normal, inflamed and cryopreserved equine hoof tissues and confirm
unique structural characteristics of progenitor cells with both mesodermal and ectodermal
antigens. This vital morphological information is invaluable to understanding the behavior
and predicting the potential of adult progenitor cells harvested from the unique dermalepidermal interface in the equine hoof that shares many features with a similar tissue
interface in the human fingernail plate and bed [275, 276]. Differences among progenitor
cells provide important clues about tissue formation and maintenance by the cells in vivo, the
de novo tissue forming potential of the cells in vitro, and the impact of cryopreservation and
antigen-based sorting on the cells. The results of this study support that differences are
maintained over multiple passages under optimal culture conditions and on 3-dimensional,
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tissue-based scaffolds. They also confirm that harvest tissue condition as well as post-harvest
preservation and cell selection all significantly impact cell structure, a general reflection of
function [277, 278].
The morphology of cells from fresh normal tissue, sorted (K14+, CD105+) and unsorted, were
largely distinguished from each other by the presence of microvilli, fewer and smaller
vacuoles, and more late endosomes dispersed throughout the cytoplasm in sorted cells. The
presence of microvilli on the sorted cells may indicate greater commitment to intense
exocytic and endocytic activity characteristic of higher plasticity [279]. Late endosomes are a
sign of a high capacity for intracellular protein recycling required for successful
differentiation in umbilical cord blood-derived multi-lineage progenitor cells [280].
Numerous vacuoles, thought to originate from dilated endoplasmic reticulum, in the
heterogeneous cell isolates also indicate cytoplasmic endo- and exocytotic activities as
documented in equine progenitor cells from other tissues [115, 223]. In both, the
ultrastructural appearance was consistent with healthy progenitor cells from equine hoof
tissue.
Cell sorting facilitates isolation of homogeneous cell populations that are reported to have
more predictable in vivo and in vitro behavior [281, 282]. The K14+,CD105+ subset of the
heterogeneous progenitor cells from normal hooves may have greater capacity for
differentiation into either ectodermal or mesodermal tissue [283]. This is suggested by the
presence of microvilli resembling filopodia, a characteristic of cells capable of epidermal to
mesodermal transition (EMT). An EMT cell signaling pathway, Wnt, has been identified in
hoof tissue [67, 284]. Notably, immunostaining further confirmed that the cells continued to
express antigens from both tissue lineages under standard culture conditions designed to
maintain a progenitor cell morphology in this study. Hence, the observed morphology is
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maintained in culture. Future work is needed to confirm the superior plasticity and EMT
potential of the sorted cells.
The cells from cryopreserved tissue showed features consistent with apoptosis including
degranulation of prevalent RER, aggregated chromatin, and an irregular cell membrane with
abundant exocytic vesicles [224, 285]. These findings are consistent with established
knowledge that cells are somewhat “aged” by thermally induced stasis and show signs of
necrosis, as well as a lower isolation rate, lower colony recovery rate and lower
reprogramming efficiency than those from fresh tissue [286-289]. Thus, though the cells were
capable of some proliferation and passage, they were unlikely to have much de novo tissue
forming capacity. Notably, the cells were maintained at a low temperature consistent with
short term preservation versus ultralow temperature for long term storage. As such, the
results are specific to the conditions tested. It is possible that customization of
cryopreservation techniques for protection of cells within tissues, isolation and preservation
of cells separately from tissue, or maintenance of the cells in the vapor phase of liquid
nitrogen may have less or different effects on the cells.
Another important finding in this study were differences in progenitor cells from normal and
inflamed tissues. The presence of lysosomes and degraded dead cells among cell isolates
from inflamed tissue suggest that the cells were functioning more in tissue breakdown than
production and maintenance [290]. The presence of cytokines, chemokines, and matrix
metalloproteinase in inflamed hooves likely influences progenitor cell behavior and reduces
plasticity of the cells [68, 291, 292], in part due to direct damage to the cells themselves [293,
294]. It is also thought that progenitor cells assume the characteristics of their environment
[295]. This finding is especially important in light of the fact that the cells had some
proinflammatory or catabolic morphology including lysosomes, irregular RER, and few
cytoplasmic vacuoles, though they were continuously cultured under optimum conditions
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following harvest. This is in contrast to some reports that cells recover in an ideal
environment [296]. Targeted work is necessary to align actual cell behavior with the
morphologies observed in this study.
Many of the features of 2-D culture observed in this investigation were maintained in in 3-D
culture, validating the 2D findings. It is especially important to note that, while cells from the
heterogenous and sorted cohorts attached to the scaffold, only the K14 +,CD105+ cells
produced detectable ECM in a relatively short period of time. This further confirms the
greater plasticity and neotissue forming capacity of the sorted cell population conveyed by
the morphology. Cells from inflamed and cryopreserved tissue did not attach well, consistent
with the apoptotic and catabolic appearance, respectively, observed in 2-D. Decellularized
tissue scaffolds have advantages over synthetic biomimetic scaffolds, and they may be the
best option for the unique equine hoof tissue interface [297, 298]. Notably, the K14+, CD105+
cells produced ectodermal and mesodermal proteins on scaffold constructs. This is promising
for translation to clinical application because implantation of progenitor cell-scaffold
constructs with well-integrated, functional cells have the best outcomes for normal tissue
formation in vivo [241, 243].
This study is limited by a single focus on cell ultrastructure. Prediction of cell behavior based
on ultrastructural morphology is well documented [299, 300]. Additionally, the cell behaviors
in 2-D culture were recapitulated in a 3-D environment. As noted above, additional side-byside comparisons of cell behaviors are required. Nonetheless, this novel work establishes a
reproducible baseline on which to design future studies surrounding equine hoof progenitor
cells.
A major attribute of this study is the direct comparison of the ultrastructure of progenitor
cells from multiple pre- and post-harvest conditions that clearly demonstrates important
differences among them. Taken together, the new information reveals that progenitor cells
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from the equine hoof stratum internum have characteristics of undifferentiated cells with
variable metabolic and synthetic capabilities determined by preharvest tissue conditions and
postharvest cryopreservation or sorting. The ultrastructural morphology information in this
study contributes to understanding of equine hoof progenitor cells to predict their potential
contributions to tissue maintenance, healing and damage as well post-implantation behavior.
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CHAPTER 4. EQUINE HOOF K14+CD105+PROGENITOR CELLS: A
MODEL FOR ALTERED TISSUE HEALING FROM EPITHELIAL TO
MESENCHYMAL TRANSITION
4.1 Introduction
Background: Epithelial to mesenchymal transition (EMT), typically considered a pathologic
neoplastic mechanism, is a normal process in epithelial tissue healing. Progenitor cells that
reside in ectodermal-dermal junctions like the equine hoof stratum internum, may have
enhanced multilineage differentiation capabilities and undergo EMT as part of normal tissue
interface homeostasis. However, current evidence suggests that inflammatory cytokines may
drive abnormal EMT and result in unbalanced tissue formation that contributes to fibrous
tissue production and disruption of the ectodermal-dermal junction.
Methods: Laminar tissue harvested from equine hooves (n=22, 11 unaffected, 11 laminitic)
was harvested for three purposes: collagenase digestion for primary progenitor cell isolation;
decellularization for tissue matrix; or cryosectioning for double (K14, CD105)
immunohistochemical labeling. Viable K14+CD105+ cells were sorted from P1
heterogeneous cell isolates. Paired evaluations of P3 heterogenous cell isolates and
K14+CD105+ cells included gene expression (E-cadherin, N-cadherin, p63, K1, K10, CD44,
CD105, β-catenin, transforming growth factor (TGF)-β1, -2, and -3) and antigen expression
(E-cadherin, N-cadherin) with qRT-PCR and flow cytometry, respectively. Cryopreserved P3
K14+CD105+ cells were cultured in stromal medium alone, stromal medium with
interleukins (IL) 2 and 6 or on decellularized laminar matrix in stromal medium for 21 days.
Total protein was extracted from cells cultured in stromal medium with and without ILs.
Proteins were separated by SDS-PAGE and 130 kD as well as 26kD bands were analyzed
with mass spectrometry. TGF- β1 protein expressed by cells were analyzed by ELISA.
Ectodermal (K1, K10, p63) and β-catenin, TGF-β1, -2, and -3 gene expression and
ectodermal (E-cadherin, K14) cell surface antigen expression was compared among culture
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conditions. Cell-tissue construct microstructure was evaluated with light microscopy
(Masson’s trichrome, H&E).
Results: Double ectodermal (K14) and mesodermal (CD105) protein expression was
confirmed both in vitro and in situ. Most equine hoof lamellatum progenitor cells are
K14+CD105+. The cells have lower ectodermal (K1, K10, p63) gene expression compared to
heterogeneous primary cell isolates, and EMT gene (E-cadherin, N-cadherin, β-catenin,
CD44, CD105) expression was similar between them. Mesodermal gene (TGF-β1,2,3, βcatenin, K1) expression was lower in K14+CD105+ cells cultured in stromal medium with
inflammatory interleukins (2 and 6) than those in stromal medium alone. K14+CD105+ cells
cultured with decellularized lamellar tissue matrix in stromal medium had higher p63, TGFβ1 and E-cadherin gene expression as well as K14 surface antigen expression than those in
stromal medium alone or with interleukins. Mass spectroscopy confirmed higher filamin A
protein and heat shock protein β-1 expression by cells cultured with stromal medium with
versus without interleukins. Cell-lamellar tissue construct microstructure consisted of a
single layer of closely aligned cells on the surface of secondary lamellae surrounded by
poorly organized fibrous matrix.
Conclusions: Majority of hoof primary progenitor cell isolates from equine hoof stratum
internum express both ectodermal and mesodermal antigens and K15+CD105+ cell
population has a higher percentage of EMT antigen expressing cells than primary progenitor
cells. Inflammatory mediators support a propensity for EMT in hoof K14+CD105+ cells
while normal matrix may inhibit this propensity.
Ectoderm wound healing process, including skin healing process, is complex and
incompletion or impairments in this process will lead a high level of morbidity and
mortality[301]. Wound healing can be interfered with one or more phases like hemostasis,
inflammation, proliferation or tissue remodeling[302]. Abnormal ectodermal scaring such as
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keloid, is an impaired wound healing process characterized by abnormal keratinocytes
proliferation and excessive deposition of extracellular matrix[303]. Current animal models
for wounding healing such as rat, murine, and porcine, in which a hole will usually be created
on the ectodermal area artificially and the wound closure rate will be determined later [304306]. However, the healing of an essential structure, epidermal-dermal interface, was not well
studied in these animal models, but is presented well in equine hoof. In equine hoof, there is
an unique epidermal-dermal tissue niche, in which the hoof stratum internum is composed of
tightly-connected preliminary and secondary epidermal and dermal tissue but separated by
basement membrane[6]. This structure can be damaged and regenerated during hoof growth
or injury. Therefore, equine hoof will be a natural model for studying dermal-epidermal
tissue repair.
Epithelial to mesenchymal transition (EMT) is a biologic process during which
polarized epithelial cells gradually transform into mesenchymal-like cells and loss their
epithelial functionality and characteristics[307]. EMT is also a key biological process in
tissue repair in which the cells around wound area will lose their intercellular adhesions and
migrate across the wound to support new tissue generation[308]. Abnormal or partial
epithelial to mesenchymal transition (EMT) in skin epithelial cells may lead a pathological
fibroproliferative wound healing process, such as skin keloid, in which the skin keratinocytes
exist EMT-related abnormalities and fail to express all the hallmarks of EMT[309].
Additionally, abnormal transforming growth factor (TGF)-β signaling pathway plays a key
role in keloid pathogenesis and leads increased motility in keratinocytes and thus induce
keloid formation[310]. Therefore, understanding abnormal cell EMT and TGF-β regulation in
EMT will be essential for perusing cell-signaling-based therapies for ectodermal tissue
healing.
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Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-a and interleukin
(IL)1-β, together with TGF- β1 will accentuate EMT in epithelial cell lineages and promote
dysregulated wound repair and was confirmed in human skin [311]. EMT signals like Wnt
signaling pathway were confirmed in epithelail basal epithelial cells in laminitis, a process
with multiple inflammatory cytokines and interleukins production, such as interleukin β,
interleukin 2, interleukin 6, tumor necrosis factor α, and interferon gamma [60, 67, 312-314].
These inflammatory cytokines as well as interleukins seem to lead abnormal EMT signaling
in laminar epithelial cell lineage and therefore cause laminar epithelial cell apoptosis, basal
cell cytoskeleton collapse, and laminar tissue fibrosis[32, 66, 67, 315, 316]. In addition,
inflammatory cytokines play a central role in laminar inflammatory responses regarding
leucocyte emigration, metabolic and vascular alterations in laminitis[210]. These
inflammation responses and alterations may further induce EMT followed with tissue fibrosis
and tissue remodeling[317]. Thus, Information about the effects of inflammatory cytokines
on laminar progenitor cells is both reasonable and vital for understating either tissue repair or
maintenance with abnormal EMT signaling pathways.
Either abnormal extracellular matrix (ECM) or ECM remodeling is one of the major
contributions to abnormal scarring. ECM degradation by matrix metalloproteinases and ECM
remodeling by changing stable ECM components will lead hypertrophic, keloid, and scarless
healings[318]. Normal tissue matrix is responsible for normal ordering of highly organized
tissues and that interacts with the local cell populations. Three-dimensional matrix is
indispensable for creating an entire cell microenvironment[319]. Cell-matrix interactions can
direct cell alignment and migration as well as apply physical signals. Decellularized tissue or
organ, as a scaffold for tissue repair, has been investigated a lot recently for the advantages of
providing normal tissue matrix that are necessary for cell proliferation[139]. Autograft or
allograft transplantation used to be the main method for tissue regeneration, however,
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problems such as high cost, limited available tissue and risks of rejection still exist for
autograft and allograft transplantation[320, 321]. Decellularized rat esophagus was reported
to have suitable compatibility for esophageal epithelial cell proliferation and keratinization by
showing normal esophagus cell layers formation and specific esophagus keratin protein
(keratin 34βE12) expression[322]. In equine, however, the optimal protocol for
decellularization of hoof laminar tissue is extremely limited. In this study, we investigate the
effect of normal tissue matrix from decellularized hoof laminar tissue on invitro
characteristics of K14+CD105+ laminar progenitor cells.
By using equine hoof as a novel epidermal-dermal wound healing model, we
investigated EMT cell signaling pathways under normal and pathological culture condition.
The two-part hypothesis tested was that K14+CD105+ equine hoof progenitor cells have
higher EMT potential than heterogeneous cell isolates and that inflammatory cytokines
promotes while decellularized normal tissue matrix inhibits EMT in K14+CD105+ cells.
More importantly, we isolated a specific hoof progenitor cell population that express both
ectodermal (K14) and mesodermal (CD105) antigens. Those K14+CD105+ progenitor cells
have great potential to undergoing EMT pathway and help with laminar tissue epidermaldermal junction regeneration after damage. Overall, this unique and vital animal model with
epidermal-dermal junctions will provide a novel insight in investigating EMT pathway, tissue
repair and ectodermal tissue generation therapies.
4.2. Materials and methods
4.2.1. Study design
Stratum internum tissue of 11 unaffected (U) and 11 laminitic (L) equine forelimb hooves
was collected after humane euthanasia for reasons unrelated to this study (Table 1). Tissue
was decellularized (n=5, U), evaluated with immunohistochemistry (n=3, U; n=2, L) for
colocalization of keratin (K) 14 and cluster of differentiation (CD) 105, or processed for
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progenitor cell isolation by collagenase digestion. H&E and trichrome Masson staining was
processed and analyzed by light microscopy (n=2, U). Cell outcome measures included
passage (P) 3 K14+CD105+ cell isolation (n=11, U; n=11, L) from passage (P) 2
heterogeneous cell isolates, double staining immunocytochemistry with P3 K14+CD105+
cells (n=2, U), gene expression of P3 heterogeneous cell isolates and K14+CD105+ cells for
CD44, CD105, E-cadherin, N-cadherin, β-catenin, K1, K10, p63, TGF-β1,2,3 (n=5, U), cell
surface antigen expression of P3 heterogeneous cell isolates and P3 K14+CD105+ cells for
E-cadherin and N-cadherin (n=5, U), gene expression of P3 K14+CD105+ cells with and
without treatments for K1, K10, p63, β-catenin, TGF- β1,2,3, cell surface antigen expression
of P3 K14+CD105+ cells with and without treatments for E-cadherin and K14 (n=5, U),
protein expression of P3 K14+CD105+ cells with and without treatments by ELISA (n=5, U),
protein expression of P3 K14+CD105+ cells with and without treatments by mass
spectrometry (n=2, U).
4.2.2. Stratum internum collection
Twenty-two horses were euthanatized for reasons unrelated to this study. Fresh hooves from
both unaffected horses (n=11) and those with laminitis (n=11) were collected right after the
euthanasia. Tissue was collected as previously described[323]. Briefly, each hoof was
cleansed with 10% blench and 0.1% chlorhexidine before tissue collection. Stratum internum
was exposed by using a reciprocating saw with sterile blades. Tissue was extracted and
cleansed with 70% ethanol and phosphate buffer saline (PBS, Hyclone, Logan, UT) with 1%
antibiotic antimycotic solution (MP Biomedical, Irvine, CA).
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Table 5. Horse Information and Involved Assays II
Age

Condition

Sex

Breed

(year)

IHC/

ICC

CD 105+,

qRT-PCR

Flow

ELISA

Mass

(Light

K14+ Cell

Stromal/(t

cytometry

Stromal/(t

spectrometry

Microsc

Isolation

reatment)

Stromal/(t

reatment)

Stromal/(trea

opy)

reatment)

tment)

7

Unaffected

Gelding

Thoroughbred

X

X

X

X

5

Unaffected

Gelding

Thoroughbred

X

X

X

X

4

Unaffected

Mare

Quarter Horse

X

X

X

X

13

Unaffected

Mare

Thoroughbred

X

X

(X)

7

Unaffected

Mare

Thoroughbred

X

(X)

8

Unaffected

Mare

Quarter Horse

16

Unaffected

Mare

Thoroughbred

X

X

12

Unaffected

Mare

Thoroughbred

X

18

Unaffected

Mare

Quarter Horse

(X)

8

Unaffected

Gelding

Thoroughbred

(X)

27

Unaffected

Gelding

20

Laminitic

4

X
X

X

X

X

X

X

X

(X)

(X)

X

(X)

(X)

(X)

X

(X)

(X)

(X)

X

(X)

X

(X)

(X)

Quarter Horse

X

(X)

(X)

(X)

X

Mare

Thoroughbred

X

X

X

Laminitic

Gelding

Quarter Horse

X

X

X

X

18

Laminitic

Mare

Thoroughbred

X

X

X

9

Laminitic

Gelding

Thoroughbred

X

X

X

18

Laminitic

Mare

Paint

X

X

16

Laminitic

Mare

Thoroughbred

X

X

(X)

X

7

Laminitic

Mare

Quarter Horse

X

(X)

(X)

(X)

9

Laminitic

Mare

Quarter Horse

X

(X)

X

(X)

14

Laminitic

Mare

Quarter Horse

X

(X)

(X)

(X)

19

Laminitic

Mare

Quarter Horse

X

(X)

(X)

(X)

12

Laminitic

Gelding

Quarter Horse

X

(X)

(X)

(X)

X

X

X

(X)

X
X

4.2.3. Heterogeneous primary cell isolation and expansion
Primary progenitor cells were isolated as previously described [323]. Stratum internum tissue
was minced well on a sterile petri dish (NuncTM IVF petri dish, Thermo Fisher Scientific,
Waltham, MA) and then digested with 1% bovine serum albumin (BSA, Sigma Aldrich, St.
Louis, MO), 0.1% type-1 collagenase (Worthington Biochemical Corporation, Lakewood, NJ)
in dulbecco’s modified eagle’s medium with Ham’s F12 nutrient mixture (DMEM-Ham’s
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F12, Hyclone). Digestion process was processed at 37 ˚C and last for 2 hours with 3dimentional agitation (5.5×g, GyroTwister™ GX-1000, Labnet, Inc., Edison, NJ). The
digestion mixture was then filtered with both 100 µm and 70 µm filter (Thermo Fisher
Scientific, China) respectively and centrifuged for 5 minutes at 250×g to get stromal vascular
fraction pellets. The SVF pellets were then resuspended in stromal culture medium (1%
antibiotic antimycotic solution (MP biomedical), and 10% characterized fetal bovine serum
(VWR Life Science, Radnor, PA) in DMEM-Ham’s F12 medium) and seeded on culture
plate (Thermo Fisher Scientific, Rochester, NY) at a density of 5x10 3 cells/cm2 under
standard culture condition (37 ˚C, 5% CO2). Medium was refreshed after the first 12 hours
and then every 2 days until 80% cell confluence. Cells were then passaged up to passage 2.
4.2.4. Immunohistochemistry
Laminar tissue was embedded in optimal cutting temperature (OCT, Sakura Finetek Inc.,
Torrance, CA) medium and solidified at -80°C, then sectioned with a cryostat (Leica®
CM1850, Sarasota, FL) and applied to slides. Sections were blocked with 10% of goat serum
(Gibco® 1788320, grand island, NY) for 2 hours at room temperature. Slides were then
incubated with K14 (Mouse, 2ug/ml, Fisher Scientific, # MA5-11599, Rockford, IL) and
CD105 (Rabbit, 0.2mg/ml, PA5-16895, Invitrogen, Rockford, IL) primary antibodies for
overnight at 4 ˚C and rinsed with TBS containing 0.025% triton for 5 times followed with 2
hours of labeled secondary antibodies (IgG-488, Donkey, 2mg/ml, 1975519; IgG-594,
Chicken, 2mg/ml, 19179547, ThermoFisher, Eugene, Oregon) incubation avoid from light.
Slides were rinsed with TBS for 3 times and then nuclei were stained with DAPI for 10
minutes at room temperature in darkness. Unstained tissue and sections incubated with
secondary antibody alone were incubated as control samples. Digital images were collected
with a fluorescent microscope (DM 4500b, Leica) equipped with a digital microscope (DFC
480, Leica).
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4.2.5. K14+CD105+ progenitor cell isolation
Cells were incubated with CD105-PE (Mouse, eBioscience # 12-1057-42, San Diego, CA),
K14 (Mouse, Fisher Scientific, # MA5-11599, Rockford, IL) antibodies (0.2 μg /ml) that
were already conjugated with PE and dylight 633 (53046, ThermoFisher, Rockford, IL)
respectively (l μl /1x106 cells) for 45 minutes in dark. Then cells were analyzed and sorted
with a FACSCalibur flow cytometer and Cell Quest Pro software (BD Biosciences, San Jose,
CA). K14+CD105+ progenitor cells were collected and cultured with the stromal culture
medium mentioned previously.
4.2.6. Immunocytochemistry
K14+CD105+ progenitor cells were seeded (5x103 cells/cm2) on a six-well culture plate
(Fisher Scientific, Denmark) and cultured until 80% of confluent. Cells were then washed
three times with PBS and fixed with 4% of paraformaldehyde overnight at 4 ˚C. Following
three times of wash with PBS, cells were permeabilized with 0.5% Triton-x100 for 20
minutes and blocked with 10% of goat serum (Gibco®, Grand Island, NY) for 1 hour at room
temperature. Cells were cultured with CD105 (Rabbit, 0.2mg/ml, # TG2603391C, Invitrogen,
Rockford, IL) and K14 (Mouse, 0.2 mg/ml, Thermo Fisher Scientific, Rockford, IL) primary
antibody for 2 hours at 37 ˚C. Then cultured with Alexa Fluor 594 chicken anti-rabbit IgG
(0.2 mg/ml, # 1917947, Thermo Fisher Scientifc, Eugene, Oregon) and Alexa Fluor 488
donkey anti-mouse IgG (# 1975519, Thermo Fisher Scientific) secondary antibodies for 1
hour at 37 ˚C in darkness. Nuclei were stained with 4, 6-diamidoino-2-phenylindole (DAPI)
for 10 minutes in darkness. Photomicrographs were analyzed with a fluorescent microscope
(DM 4500b, Leica) equipped with a digital camera (DFC 480, Leica).
4.2.7. Mass spectrometry
Protein samples were separated by running sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) assays. Gels were then stained with 0.5% Coomassie blue and
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gel bands around 130KD and 26KD were excised. Gel bands were destained with 50% of
acetonitrile and 50mM ammonium bicarbonate solution. Sequence grade, modified bovine or
porcine trypsin (Sigma Aldrich, 12.5ng/ml) was used for in-gel digestion. Digestion was
processed at 37 oC overnight and stopped by adding 10% formic acid solution. Peptides were
extracted with 50% of acetonitrile and 50mM ammonium bicarbonate solution followed with
another extraction with 100% of acetonitrile. Extracted peptides were then concentrated and
dried for spectrometric analysis with an AmaZon speed ETD Ion Trap mass spectrometer
(Bruker Daltonics, Billerica, MA, USA). Mass detection was performed in full-scan mode in
positive ionization enhanced resolution mode with the scan speed of 8100 m/z/s. The
software used for data processing and de-convolution was Compass DataAnalysis (Bruker
Daltonics). Identification of the proteins was accomplished on the basis of the NCBIprot
database using the MASCOT search program (Matrix Science, London, UK) from the
peptides generated from the digest. A mass deviation of < 0.2 Da and one missed cleavage
were allowed in the database searches.
4.2.8. Enzyme linked immunosorbent assay (ELISA)-TGF- β1
A commercially available equine TGF-β1 kit (Genorise Scientific, Glen Mills, PA) was used.
A seven-point standard curve was generated using 2-fold serial dilutions with TGF-β1
standard. Cell culture medium samples were activated with 1 N HCI for 10 minutes and
neutralized with neutralization buffer before use. Samples and standard were vortexed well
before adding to the antibody-coated 96-well plate, the plate was then covered and incubated
1.5 hour at room temperature. Then each well was aspirated and washed with assay buffer for
3 times followed with another one-hour culture with detection antibody at room temperature.
After 3 times of washing with assay buffer, HRP conjugate was added to each well and
incubated for 20 minutes avoid from light. Then each well was washed with assay buffer for
3 times and incubated with substrate solution for 20 minutes avoid from light. Finally stop
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solution was added to each well and the plate was gently tapped to ensure thorough mixing.
TGF- β1 protein concentration was quantified by absorption at 450nm and a wavelength
correction was set at 540nm.
4.2.9. Target gene expression (qRT-PCR)
Equine specific primers were designed for CD44, CD105, K1, K10, p63, E-cadherin, Ncadherin, TGF- β1, TGF- β2, TGF- β3, and β-catenin. Total mRNA was extracted from P3
heterogeneous cell isolates and K14+CD105+ progenitor cells with a mRNA isolation kit
(RNAqueous Micro Kit, Ambion, Inc., Austin, TX), and NanoDrop technique (Montchanin,
DE, USA) was used to determine the concentration. Then cDNA was generated with a
quantiTect reverse transcription kit (Qiagen, GmbH, Germany). Target gene mRNA levels
were quantified with qRT-PCR using SYBR green technology (Qiagen) and an mJ research
chromo4 detector (Bio-rad laboratories, Herules, CA). The ΔCt values were determined
relative to the reference gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Table 6. Primer Sequences Information for K14+CD105+ and Heterogeneous Equine Hoof
Progenitor Cells
Gene

Forward

Reverse

Accession No.

GAPDH

CAATGACCCCTTCATTGACC

GAAGATGGTGATGGCCTTTC

NM_001163856

K1

CAACAAGCGGACAAATGC

CGGACCTCAGCGATAATG

NM_001346199

K10

GCTCGCCTACCTGAAGAAG

CTCCAGACCTTGAACAGTG

NM_001346076

P63

ATCAACCCTCAGCAGCG

ATGAACAGCCCAACCTCG

XM_023623496

β catenin

CAGGTGGTGCTGAATAAGG

GTTGTGGAGAGTTGTAATGG

XM_023619816

E cadherin

CATTGTGTACTCCATCCTCAGC

TGTACTTAAGCCCTCACCTTGA

XM_023637192

N cadherin

TGCCGGCACCATGTTAACAA

GCCAATTGGCAGGATCAGAT

XM_023647607

TGF β1

AGCCTGAGGCGGACTACT

GCCGGTCTCCACAGTCTTAT

XM_005596086

TGF β2

ATGCCAACTTCTGTGCTGGA

ACACACAGCAAGGAGAAGCA

XM_005608026

TGF β3

TGGAACCAACCTGTTCCGAG

GCGTTGTTTGGCGATATGCT

XM_001492687

CD44

GTGTGGACAGAAGAAGAAGCT

CAATCTTCATGTCCACATTCTGC

XM_023653788

CD105

GACGCCAATCACAACATACA

TCCACATAGGACGCTACGAC

XM_003364144
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4.2.10. Flow cytometry
Cell aliquots (106 cells) were suspended in 800ul of 1% BSA containing 0.2% of sodium
azide. Monoclonal labeled antibodies E-cadherin-488 (Rat, 0.5 mg/ml, 53-3249-82,
ThermoFisher, Carlsbad, CA), N-cadherin-PE (Mouse, 50mg/ml, 12-3259-42, ThermoFisher,
Carlsbad, CA), K14 (Mouse, Fisher Scientific, # MA5-11599, Rockford, IL) with a dylight
633 label (Fischer Scientific) were added to the cell suspension and incubated for 45 minutes
at 4 degree avoid from light. Cells were then washed and resuspend with PBS. Cells were
not incubated with antibodies were used as autofluorescence control. Cell fluorescence was
analyzed with a FACSCalibur flow cytometer and Cell Quest Pro software (BD Biosciences,
San Jose, CA).
4.2.11. Stratum internum tissue decellularization and cell construct culture
Stratum internum tissue (5 x 5 x 5 mm) was decellularized with 0.1% EDTA and 0.5% SDS
solution as previously described [324]. After decellularization, samples were moved into PBS
for 1 hour and then lyophilized (-55˚C, VirTis BenchTop, Stanford, TX) for 12 hours.
Lyophilized tissues were sterilized with ethylene oxide prior to addition of cells. Cell pellets
were resuspended in 100 μl of stromal medium. A total of 3x106 cells were added to stratum
internum tissue scaffolds by pipetting to give a cell density of 2.4x104/mm3. Constructs were
cultured in 12 well plates (Fisher Scientific, Denmark) with stromal medium for a total of 21
days under standard culture conditions (5% CO2, 37◦C) and medium was refreshed every 3
days.
4.2.12. Light microscopy
Hematoxylin & eosin (HE) staining
P3 K14+CD105+ progenitor cell and tissue constructs were embedded with paraffin and
sectioned into slides. Then slides were deparaffinized with xylene and ethanol and followed
with a deionized water wash. After that slides were stained with hematoxylin for 8 minutes
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and then washed with tap water for 3 minutes. Then slides were stained with eosin-phloxine
for 30 seconds followed with dehydration in 95% alcohol for 10 minutes. Finally, slides were
clear in xylene for 5 minutes and mounted with xylene based mounting medium.
4.2.13. Trichrome masson staining
Cell and tissue constructs were embedded with paraffin and sectioned into slides. Slides were
deparaffinized with mordant in Bouin’s solution for overnight. After washing with tap water,
slides were stained with Weigert’s iron hematoxylin solution and Biebrich scarlet acid
solution. Then slides were placed in phosphomolybdic acid solution, aniline blue solution and
acetic acid solution for 5 minutes, respectively. Finally, slides were dehydrated with 95%
alcohol and clear in xylene.
4.2.14. Statistical analysis
Statistical analyses were processed with commercially available software (SAS 9.2, Institute,
Cary, NC). Analysis of variance (ANOVA) models were used to measure K14+CD105+ cell
percentages within passages, surface antigen expression and multiple gene expression levels.
Unpaired T-test models were used to measure cell surface marker expression, CD, and DT.
Tukey’s post hoc tests were applied for multiple group comparisons (p<.05).
4.3. Results
4.3.1. Immunohistochemistry (K14, CD105)
Double fluorescent immunohistochemistry labeling confirmed the presence of both K14 (Fig.
35 A, B) and CD105 (Fig. 35 D, E) proteins, mostly on the tip of secondary epidermal
laminae.

81

Figure 35. Fluorescent photomicrographs of lamellae form unaffected hooves labeled with
antibodies against K14 (A, B) and CD105 (D, E). Red and green fluorescence merge in
yellow (C, F).
4.3.2. Immunocytochemistry (K14, CD105)
Fluorescent immunocytochemistry labeling confirmed the presence of both K14 (Fig. 36 A)
and CD105 (Fig. 36 B) on P3 K14+CD105+ progenitor cells.

Figure 36. Fluorescent photomicrographs of P3 cultured hoof K14+CD105+ progenitor cells.
K14 (green, A), CD105 (red, B) protein expression were double detected at the same time
and same place. Combined staining graph (yellow, C). Nuclei were stained with DAPI (blue,
D). Bar = 100μm
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4.3.3. K14+CD105+ progenitor cell percentages
The percentage of single K14 positive cells was found higher in unaffected hooves and single
CD105 positive cells were extremely low in both unaffected and laminitic hooves. Most cell
populations in equine hoof are double positive cells (Fig. 37 A). K14+CD105+ progenitor
cells were isolated from both unaffected and laminitic hooves up to passage 2 and occupied
80% of the total cell composition (Fig. 37 B). From passage 0 to passage 2, the percentages
of K14+CD105+ progenitor cells are lower in laminitic hooves than unaffected hooves with
no significant differences among passages (Fig. 37 C).

Figure 37. Percentages of single K14+ or CD105+ positive cells (A), double K14+CD105+
cells (B), and K14+CD105+ progenitor cells within cell passages 0-2 (C) in both unaffected
and laminitic hooves (mean±SEM). Columns stand for K14+ cells are distinct from each
other (P < .05).
4.3.4. Flow cytometry-E-cadherin, N-cadherin
P3 cultured progenitor cells and K14+CD105+ progenitor cells from unaffected hooves
expressed both E-cadherin and N-cadherin. E-cadherin expression in unsorted cells and
K14+CD105+ cells are 43.4 ± 3.9 and 68.0 ± 4.7 respectively. N-cadherin expression
percentages in unsorted and K14+CD105+ cells are 22.5 ± 6.3 and 41.3 ± 7.8 respectively. Ecadherin expression is significantly higher in K14+CD105+ progenitor cells compared to
unsorted cells, and E-cadherin expression is significantly higher than N-cadherin expression
in K14+CD105+ cells (Fig. 38).
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Figure 38. Percentage (mean ± SEM) of E-cadherin+ (black) and N-cadherin+ (gray)
K14+CD105+ progenitor cell and unsorted cells from unaffected hooves. Columns with
different letters and columns with symbols are distinct from each other (P<.05).
4.3.5. Target gene expression (qRT-PCR)
Gene expression of K1, K10, p63 by P3 K14+CD105+ progenitor cell and unsorted
heterogeneous cell isolated from unaffected hooves were conformed (Fig. 39 A). In addition,
EMT gene includes CD44, CD105, β-catenin, E-cadherin, N-cadherin, and TGF-β1, -2, -3
expression were found in both K14+CD105+ progenitor cell and unsorted heterogeneous cell
isolates (Fig. 39 B). K1 expression is significantly higher in unsorted cells compared to
K14+CD105+ cells.

Figure 39. Expression levels (ΔCT, mean ± SEM) of K1, K10, p63 (A), CD44, CD105, βcatenin, E-cadherin, N-cadherin, TGF- β1, -2, -3(B) in P3 K14+CD105+ progenitor cells and
unsorted heterogeneous isolates from unaffected hooves. Reference gene: GAPDH. Columns
stand with different letters are distinct from each other (P<.05).
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4.3.6. HE and trichrome masson staining
H&E (Fig. 40 A, B, C) and Trichrome Masson staining (Fig. 40 D, E, F) confirmed cell
attachment on decellularized laminar scaffold. In scaffold loaded with cells, the secondary
epidermal laminae attached to the sides of the primary epidermal laminae tightly (Fig. 40, B,
E) while in scaffold without loading cells, the secondary epidermal laminae did not attach to
primary epidermal laminae (Fig. 40 C, F). Attached cells were closely aligned in a single
layer along secondary lamellae and surrounded by some poorly organized fibrous matrix (Fig.
40 B, E). Control group doesn’t show cell staining (Fig. 40 C, F).

Figure 40. Light photomicrographs of lamellae stained with HE (A, B, C) and trichrome (D,
E, F). Cell nucleus were stained dark purple, matrix and cytoplasm were stained pink or red,
collagen fibrils were stained blue.
4.3.7. Surface antigen and gene expression in K14+CD105+ cells with different culture
condition
E-cadherin surface antigen expression (Figure 41 A) is significantly lower (20.9 ± 6.8) in
cells cultured with IL medium compared to cells cultured with normal matrix (72.1 ± 1.7) and
stromal medium (50.1 ± 4.9). Ectodermal gene (K1, p63) expression (Figure 41 B) is
significantly lower in cells cultured with IL medium (ΔCT 8.8 ± 0.7, 12.9 ±0 .3) compare to
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cells cultured with normal matrix (ΔCT 4.9±0.5, 8.8±0.4) and stromal medium (ΔCT 4.0 ±
0.4, 10.6 ± 0.3). TGF-β1, -2, -3 and β-catenin gene expression (Figure 41 B) is significantly
higher in cells cultured with stromal medium (ΔCT -1.5 ± 0.3, -6.1 ± 0.4, -4.3 ± 0.3, 10.0±0.3) compared to cells cultured with IL medium (ΔCT 1.6 ± 0.3, -3.4 ± 0.4, -2.1 ± 0.7, 6.4 ± 0.7). TGF-β1gene expression is significantly higher in cells cultured with matrix (ΔCT 2.2 ± 0.2) compared to cells cultured with IL medium (ΔCT 1.6 ± 0.3).

Figure 41. E-cadherin and K14 surface antigen (A) percentages (mean ± SEM) and gene
expression (B) levels (ΔCT, mean ± SEM) of TGF- β1, -2, -3, β-catenin, K1, K10, and p63
from P3 K14+CD105+ progenitor cells cultured with stromal medium, IL medium and
normal matrix. Reference gene: GAPDH. Columns with different letters are significantly
different among treatments or gene (P < .05).
4.3.8. Enzyme Linked Immunosorbent Assay (ELISA)-TGF-β1
There is a significantly lower TGF- β1 protein expression in the culture medium of cells
cultured with IL medium (214.6±30.4 pg/ml) compared to cells cultured with stromal
medium (403.1±45.0pg/ml) (Figure 8, B). TGF- β1 protein expression is slightly higher in the
culture medium of cells cultured with normal matrix (249.6±42.4 pg/ml) compared to cells
cultured with IL medium (Fig. 42).
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Figure 42. The 7 points standard curve used to determine sample concentrations (A). Total
TGF- β1 protein expression in the culture medium of cells cultured with stromal medium, IL
medium and normal matrix (B). Columns with different letters are significantly different
among treatments (P < .05).
4.3.9. Mass spectrometry
Results indicate that peptides from protein bands at 130kD and 26kD (Fig. 43) were
significantly different between cells cultured with IL medium and stromal medium (Fig. 44).
Protein expression of filamin A and heat shock protein (HSP)-β1 is significantly higher in
cells cultured with IL medium compared to cells cultured with stromal medium (Fig. 44 E, F).

Figure 43. Photograph of SDS-PAGE gel with protein bands (black). Size markers (1, 2)
show a range between 10 kD and 170kD. Proteins were from cells cultured with IL medium
(3, 4) and stromal medium (5, 6). Protein bands between 130kD and 170kD (long arrows) or
between 17 kD and 26kD (short arrows) were selected for EMT protein analysis.
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Figure 44. Relative absorbance photograph of mass spectrometry analysis from protein
peptides extracted from cells cultured with IL medium (A, C) and stromal medium (B, D).
Mascot protein score (E, F) of filamin A and HSP-β1 protein, score greater than 94 was
considered significant (p<.05).

4.4. Discussion
The results of this study clearly demonstrate the important effects of inflammatory
interleukins and normal tissue matrix on equine hoof K14+CD105+ progenitor cells and
confirm the EMT potential of both hoof heterogeneous and K14+CD105+ cell population.
This vital in vitro progenitor cell behavior information is invaluable to understanding the
behavior and predicting the EMT potential of hoof progenitor cells under either inflammatory
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or normal culture condition. Laminitis is a multifactorial condition defined as inflammation
of sensitive hoof tissues but also recognized pathologic changes with or without
inflammatory mediators[325]. Information about equine hoof progenitor cell population and
impact of inflammation as well as matrix on progenitor cells provides essential clues about
cell signaling pathways in different cell populations under different culture condition, and
abnormal tissue formation as well as normal tissue maintenance by cells in different
microenvironments.
Investigations of progenitor cells that have both dermal and ectodermal characteristics
can provide guidance for dermal and ectodermal tissue engineering[326]. Current studies
focus on investigating enzymes or molecules associated with epidermal-dermal junction
membrane formation or perturbation[327-329],

but information about progenitor cells

around epidermal-dermal junction that may help with interface protection or regeneration is
largely limited. Only few studies mentioned stem cells around dental pulp membrane
junction[330]. Epidermal-dermal junction is a function unit involved with epidermal-dermal
adherence, integrity and epidermis mechanical support. It is a membrane associate complex
in maintaining the stable link between basal epithelial cells and dermis[331, 332]. Usually it
is connected with epidermis basal cell layers, basal cell membrane and regular-distributed
filamentous structures[333]. Epidermal cells were found to migrate through dermalepidermal interface in wound healing process [334-337]. In equine hoof, laminar dermal and
epidermal connection dysadhesion or degradation is a common pathological condition in
equine laminitis[110]. This process is associated with the loss of type IV, VII collagen,
laminin, and activation of matrix metalloproteinases[338-340]. Downregulation of
desmosomal proteins or hemidesmosomes is another reason for the failure of hoof dermalepidermal attachment[53, 341].
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Cell fate is not always deterministic and there is an intermediate (transitional) cell state from
which the cells can be converted through reprograming [342, 343]. The history of changing
cell history began in 1990s, when cell oocyte-mediated nuclear transfer reprogramming was
firstly introduced [344]. After that ectopic transcription factors were found to induce
transdifferentiation and produce induced pluripotent stem cells (iPSCs) from adult somatic
cells [345]. However, nuclear transfer reprogramming faced a number of ethical issues
because nuclear transfer embryonic stem cells have been generated using human cells and
therefore has very limited clinical applications [346]. Transcription factor-based cell
reprograming also show drawbacks because the insertion of vectors in reprogramming
process may cause unintended outcomes [347]. Recently, studies are focusing on chemical
reprogramming, from which some chemical molecules were used for iPSCs [342]. Chemical
reprogramming usually needs a long period to get iPSCs but is a much safer way than the
previous two reprogramming techniques [348, 349]. In this study, we also found an
intermediate cell population from equine hoof tissue, K14+CD105+ progenitor cells, and
their cell fate can be converted with chemical reprogramming assay. Taken together, results
in this study provide novel information on equine hoof cell population and potential
progenitor cell based therapeutic strategies to restore hoof tissue.
Epithelial to mesenchymal transition (EMT) is an established mechanism by which the
epithelial cells lose their epithelial characteristics and become migratory mesenchymal cell
lineage [350].

Notably, EMT process includes disruption of cell to cell junctions and

increased inflammatory cytokine expression, similar to consequences of equine laminitis [351,
352]. Therefore, expression of EMT markers in this study indicating EMT pathway may be
one of the critical cell-signaling pathways happens in laminitis. In addition, the EMT
pathway may explain the situation that cells cannot fully keratinized in hooves with laminitis.
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By inhibiting EMT signaling pathway in hoof cells, the laminitis symptoms could be reduced
at some degree.
Inflammation factors are essential clinical signals for transplantation or tissue regeneration
therapies and were associated with alloimmune and no-alloimmune epithelial injuries.
Inflammatory cytokines or pre-inflammatory cytokines were found to accentuate EMT and
dysregulate airway epithelial repair in human[311]. In our study, the results also indicate
inflammatory interleukins promote EMT proteins and gene expression in equine hoof
progenitor cells. Therefore, by stopping the inflammation process of hoof injuries may inhibit
EMT in hoof cells and consistent abnormal hoof tissue formation. This may explain the use
of anti-inflammatory drugs in equine laminitis treatments[353]. However, the concentration
of inflammatory cytokines in injured hooves is variable and unknown in most cases, our
study only investigated the effect of one concentration of inflammatory cytokines on hoof
progenitor cells, which is one limitation of the study. Therefore, future studies should detect
several inflammatory cytokine concentrations and document the possible different outcomes
from each concentration.
Taken together, our results confirm that the majority of progenitor cell isolates from the
equine hoof epidermal-dermal interface express both ectodermal and mesodermal antigens
and that the K14+CD105+ cell population has a higher percentage of EMT surface antigen
expressing cells than heterogeneous primary cells. This suggests that cell plasticity required
to maintain both the interface and two tissue types may be enhanced by EMT capabilities.
The most relevant gene expression results confirmed the lowest mesodermal gene expression
in cells cultured with versus without matrix, supporting the hypothesis. Protein expression,
however, strongly supports the ability of the cells to assume either ectodermal or mesodermal
phenotypes and that inflammatory mediators may support a propensity for EMT. This study
creates a unique and valuable invitro model for study of equine hoof progenitor cell EMT to
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design preventative and restorative therapies for equine laminitis or other equine hoof injuries
and diseases.
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CHAPTER 5. SUMMARY AND FUTURE STUDIES
The focus of this dissertation is to isolate, identify and characterize a progenitor cell
from equine hoof stratum internum, varying pre- and post-harvest conditions. In the past
decades, equine hoof studies mainly include investigations about hoof structure, hoof growth,
hoof physiology, hoof diseases, hoof mechanical testing, and shoeing. There is relatively
limited information about hoof progenitor cells and progenitor cell behaviors, which is
critical for understanding hoof organization and regeneration. Only a few studies report about
hoof basal cells and epithelial cells in vivo as well as using mesenchymal stem cells to treat
laminitis. Therefore, more information is necessary to contribute to the understanding of
equine hoof progenitor cells from multiple harvest conditions in tissue maintenance, damage,
regeneration as well as post-implantation behaviors. Hoof progenitor cells show similar in
vitro characteristics relative to other reported progenitor cells, but in vitro behaviors will
change in response to other factors, such as cryopreservation, inflammatory interleukins, and
tissue matrix. This dissertation describes creation of an in vitro model for characterizations
of equine hoof progenitor cells at genetic, protein and ultrastructural levels. This information
can be used to inform future therapeutic treatment of equine laminitis, improving prognosis
through cell-based implantation.
We illustrated how to isolate progenitor cells in the second chapter of this dissertation
with a documented protocol in our laboratory. We found the enzyme digestion outcomes may
be varied in different tissue and species. The enzyme concentration and digestion time are
closely correlated with a cell survival rate as well as the final cell yield. In this study, we
only chose one proper enzyme concentration and digestion time for equine hoof progenitor
cell isolation, which is not enough for getting the best outcomes of hoof progenitor cell
isolation. With different isolation conditions, equine hoof progenitor cells may behave
similarly or significantly differently in vitro. Thus, our information provides important
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information for future studies on investigating proper enzyme concentration levels and
digestion times to get the robust cell population.
Based on the gene and protein expression data from the second chapter of this
dissertation, we concluded that progenitor cells isolated from equine laminar tissue are not
homogeneous. Those heterogeneous cell populations show both ectodermal and dermal
protein and gene expressions but the expressions are variable among samples. Currently, we
cannot know the exact stage of laminitis for every tissue sample we got, so we do not know if
different pathological conditions of the tissue sample would affect the characteristics of
progenitor cells isolated from. This could be one reason to explain the variations among
different samples. Therefore, in the third and fourth chapters, we discussed how to sort the
heterogeneous cell population to get a more homogeneous and consistent cell population, the
K14+CD105+ cell population. K14+CD105+ progenitor cells show strong in vitro
proliferation and consistent ectodermal and dermal gene as well as protein expression. EMT
antigen and gene expression was more consistent in K14+CD105+ cells compared to
heterogenous cell population. This novel cell population provides further evidence for the
existence of EMT in equine hoof and therefore showing the therapeutic potential of using
K14+CD105+ cells in treatments.
Based on our data in chapter two and three, we know that gene and protein expression
in both normal and laminitic groups are not significantly different, but cell morphology is
distinct among different harvest conditions. The reason could be that we cultured cells from
normal and laminitic hooves in the same culture condition that is ideal for cell growth and
proliferation. Therefore, those hoof progenitor cells will finally show similar phenotypes after
several passages. But ultrastructure results still indicate the different characteristics of
progenitor cells from different harvest conditions. We also pointed out the significant effects
of cryopreservation on hoof progenitor cells. Next, to mimic the inflammatory growth
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condition in the real laminitic hoof, we added interleukins factors into culture medium and
found inflammatory interleukins do affect the in vitro behaviors of hoof progenitors.
Progenitor cells cultured with inflammatory interleukins express lower levels of ectodermal
genes, surface antigens and proteins compared to cells cultured in stromal medium, indicating
the loss of epithelial characteristics. This could be one of the possible reasons that explain
why cells proliferate abnormally and form abnormal tissue in the inflamed hoof. Therefore,
our results suggest that stopping inflammatory cell signaling, such as interleukin 2 and 6, in
laminar progenitor cells could be a novel approach to assist normal hoof tissue generation
after damage and providing a new perspective for future investigations.
Finally, we illustrated how normal tissue matrix will influence K14+CD105+
progenitor cells. The results indicate that normal tissue matrix promotes K14+CD105+
progenitor cell keratinization, which displays the opposite effects of inflammatory
interleukins culture condition mentioned above. However, future studies should include
optimization of cell culture after sorting to minimize the culture period of K14+CD105+
progenitor cells. We proved that K14+CD105+ progenitor cells cultured with normal matrix
express higher ectodermal antigen and gene expression as well as producing the organized
fibrous matrix. In addition, we found fibrous matrix deposition on the decellularized laminar
scaffold after loading with hoof progenitor cells isolated from other harvest conditions. This
vital information suggests that hoof progenitor cells can survive and proliferate well after
loading on the matrix-derived scaffold, which would contribute to a new therapeutic option
for hoof tissue damage, such as cell-based scaffold implantation therapies designed for
equine hoof tissue regeneration.
As a whole, this study has summarized evidence that equine hoof multipotent
progenitor cells play a role in either normal or abnormal hoof tissue formation, and that
sustained abnormal EMT may be a key mechanism underlying the fibrotic pathology of
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laminitis. Cell ultrastructure morphology and cell sorting results provide invaluable
information for representing a way forward to the potential targeting of cell populations as a
novel therapeutic approach for tissue healing. The inflammatory and 3D cell treatments
developed in this study may have wide applicability for future equine progenitor research and
in human stem cell investigations with inflammatory mediators. Further understanding of all
the information above may allow the identification of novel therapeutic targets. All the
outcomes in this project will contribute to future cell-based wound repair studies and
orthopedic treatments.
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